{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:35:56Z","timestamp":1792575356938,"version":"4.5.0"},"reference-count":384,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40266-025-01252-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:04:09Z","timestamp":1759928649000},"page":"1113-1142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sarcopenia and Cachexia in Older Patients with Cancer: Pathophysiology, Diagnosis, Impact on Outcomes, and Management Strategies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-8701","authenticated-orcid":false,"given":"Efthymios","family":"Papadopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Heymsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schroder","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir M. H.","family":"Alibhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"publisher","DOI":"10.1200\/OP-24-00781","author":"MD Goncalves","year":"2025","unstructured":"Goncalves MD, Dunne RF, Moore AC, Phillips W, Heymsfield SB, Brown JC, et al. Call to improve coding of cancer-associated cachexia. JCO Oncol Pract. 2025. https:\/\/doi.org\/10.1200\/OP-24-00781.","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"1252_CR2","first-page":"15","volume":"14","author":"Y Rolland","year":"2011","unstructured":"Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care. 2011;14(1):15\u201321.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1252_CR3","first-page":"410","volume":"27","author":"F Bozzetti","year":"2024","unstructured":"Bozzetti F. Age-related and cancer-related sarcopenia: is there a difference? Curr Opin Clin Nutr Metab Care. 2024;27(5):410\u20138.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1252_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121861","author":"RF Dunne","year":"2019","unstructured":"Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11121861.","journal-title":"Cancers (Basel)"},{"issue":"19","key":"1252_CR5","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1200\/JCO.21.00102","volume":"39","author":"GR Williams","year":"2021","unstructured":"Williams GR, Dunne RF, Giri S, Shachar SS, Caan BJ. Sarcopenia in the older adult with cancer. J Clin Oncol. 2021;39(19):2068\u201378.","journal-title":"J Clin Oncol"},{"issue":"5 Suppl","key":"1252_CR6","doi-asserted-by":"publisher","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990S-S991.","journal-title":"J Nutr"},{"issue":"5","key":"1252_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/ajcn\/50.5.1231","volume":"50","author":"IH Rosenberg","year":"1989","unstructured":"Rosenberg IH. Summary comments. Am J Clin Nutr. 1989;50(5):1231\u20133.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1252_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14283\/jfa.2017.30","volume":"7","author":"B Vellas","year":"2018","unstructured":"Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2018;7(1):2\u20139.","journal-title":"J Frailty Aging"},{"issue":"4","key":"1252_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601.","journal-title":"Age Ageing"},{"issue":"9","key":"1252_CR10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","volume":"186","author":"M Ferrer","year":"2023","unstructured":"Ferrer M, Anthony TG, Ayres JS, Biffi G, Brown JC, Caan BJ, et al. Cachexia: a systemic consequence of progressive, unresolved disease. Cell. 2023;186(9):1824\u201345.","journal-title":"Cell"},{"issue":"3","key":"1252_CR11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s10120-015-0546-4","volume":"19","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2016;19(3):986\u201393.","journal-title":"Gastric Cancer"},{"key":"1252_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/nu15061508","author":"C Martinez-Tapia","year":"2023","unstructured":"Martinez-Tapia C, Rougette K, Fossey-Diaz V, Cudennec T, Taleb C, Balardy L, et al. Prevalence of four sarcopenia criteria in older patients with cancer, and their predictive value for 6-month mortality: the NutriAgeCancer national prospective cohort study. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15061508.","journal-title":"Nutrients"},{"issue":"2","key":"1252_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1245\/s10434-015-4887-3","volume":"23","author":"SL Wang","year":"2016","unstructured":"Wang SL, Zhuang CL, Huang DD, Pang WY, Lou N, Chen FF, et al. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol. 2016;23(2):556\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1252_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jso.24015","volume":"112","author":"JJ Tegels","year":"2015","unstructured":"Tegels JJ, van Vugt JL, Reisinger KW, Hulsewe KW, Hoofwijk AG, Derikx JP, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112(4):403\u20137.","journal-title":"J Surg Oncol"},{"issue":"7","key":"1252_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jgo.2022.03.008","volume":"13","author":"Q Sun","year":"2022","unstructured":"Sun Q, Jiang X, Qin R, Yang Y, Gong Y, Wang K, et al. Sarcopenia among older patients with cancer: a scoping review of the literature. J Geriatr Oncol. 2022;13(7):924\u201334.","journal-title":"J Geriatr Oncol."},{"issue":"6","key":"1252_CR16","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/jcsm.12776","volume":"12","author":"J Poisson","year":"2021","unstructured":"Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, et al. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477\u201388.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1252_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jgo.2018.08.008","volume":"10","author":"RF Dunne","year":"2019","unstructured":"Dunne RF, Roussel B, Culakova E, Pandya C, Fleming FJ, Hensley B, et al. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol. 2019;10(3):415\u20139.","journal-title":"J Geriatr Oncol"},{"issue":"9","key":"1252_CR18","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1002\/nop2.1872","volume":"10","author":"B Owusu","year":"2023","unstructured":"Owusu B, Bivins B, Marseille BR, Baptiste DL. Aging in place: programs, challenges and opportunities for promoting healthy aging for older adults. Nurs Open. 2023;10(9):5784\u20136.","journal-title":"Nurs Open"},{"key":"1252_CR19","first-page":"147","volume":"117","author":"NA Berger","year":"2006","unstructured":"Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147\u201355 (discussion 55-6).","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"3","key":"1252_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ageing\/afy212","volume":"48","author":"L Otten","year":"2019","unstructured":"Otten L, Stobaus N, Franz K, Genton L, Muller-Werdan U, Wirth R, et al. Impact of sarcopenia on 1-year mortality in older patients with cancer. Age Ageing. 2019;48(3):413\u20138.","journal-title":"Age Ageing"},{"key":"1252_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092094","author":"RT Morse","year":"2022","unstructured":"Morse RT, Ganju RG, Gan GN, Cao Y, Neupane P, Kakarala K, et al. Sarcopenia and treatment toxicity in older adults undergoing chemoradiation for head and neck cancer: identifying factors to predict frailty. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14092094.","journal-title":"Cancers (Basel)"},{"key":"1252_CR22","doi-asserted-by":"publisher","first-page":"1416569","DOI":"10.3389\/fnagi.2024.1416569","volume":"16","author":"B Dong","year":"2024","unstructured":"Dong B, Yu D, Zhang H, Li P, Li Y, Li C, et al. Association between preoperative sarcopenia and postoperative delirium in older patients undergoing gastrointestinal cancer surgery. Front Aging Neurosci. 2024;16:1416569.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1252_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4783","volume":"3","author":"GR Williams","year":"2020","unstructured":"Williams GR, Chen Y, Kenzik KM, McDonald A, Shachar SS, Klepin HD, et al. Assessment of sarcopenia measures, survival, and disability in older adults before and after diagnosis with cancer. JAMA Netw Open. 2020;3(5):e204783.","journal-title":"JAMA Netw Open"},{"issue":"25","key":"1252_CR24","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1200\/JCO.23.01280","volume":"41","author":"EJ Roeland","year":"2023","unstructured":"Roeland EJ, Bohlke K, Baracos VE, Smith TJ, Loprinzi CL, Cancer Cachexia Expert P. Cancer cachexia: ASCO guideline rapid recommendation update. J Clin Oncol. 2023;41(25):4178\u20139.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1252_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100282","volume":"15","author":"T Takaoka","year":"2024","unstructured":"Takaoka T, Yaegashi A, Watanabe D. Prevalence of and survival with cachexia among patients with cancer: a systematic review and meta-analysis. Adv Nutr. 2024;15(9):100282.","journal-title":"Adv Nutr"},{"issue":"5","key":"1252_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afw090","volume":"45","author":"DM Mijnarends","year":"2016","unstructured":"Mijnarends DM, Koster A, Schols JM, Meijers JM, Halfens RJ, Gudnason V, et al. Physical activity and incidence of sarcopenia: the population-based AGES-Reykjavik study. Age Ageing. 2016;45(5):614\u201320.","journal-title":"Age Ageing"},{"issue":"4","key":"1252_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.clnu.2011.12.008","volume":"31","author":"NA Stephens","year":"2012","unstructured":"Stephens NA, Gray C, MacDonald AJ, Tan BH, Gallagher IJ, Skipworth RJ, et al. Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr. 2012;31(4):499\u2013505.","journal-title":"Clin Nutr"},{"issue":"8","key":"1252_CR28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00109-007-0220-3","volume":"85","author":"MA Weber","year":"2007","unstructured":"Weber MA, Kinscherf R, Krakowski-Roosen H, Aulmann M, Renk H, Kunkele A, et al. Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting? J Mol Med (Berl). 2007;85(8):887\u201396.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"1252_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/02841860802130001","volume":"48","author":"MA Weber","year":"2009","unstructured":"Weber MA, Krakowski-Roosen H, Schroder L, Kinscherf R, Krix M, Kopp-Schneider A, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol. 2009;48(1):116\u201324.","journal-title":"Acta Oncol"},{"issue":"1","key":"1252_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05569-y","volume":"24","author":"P Perez-Ros","year":"2024","unstructured":"Perez-Ros P, Barrachina-Igual J, Pablos A, Fonfria-Vivas R, Cauli O, Martinez-Arnau FM. Diagnostic accuracy of isometric knee extension strength as a sarcopenia criteria in older women. BMC Geriatr. 2024;24(1):988.","journal-title":"BMC Geriatr"},{"issue":"4","key":"1252_CR31","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/jcsm.13248","volume":"14","author":"S Hadzibegovic","year":"2023","unstructured":"Hadzibegovic S, Porthun J, Lena A, Weinlander P, Luck LC, Potthoff SK, et al. Hand grip strength in patients with advanced cancer: a prospective study. J Cachexia Sarcopenia Muscle. 2023;14(4):1682\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1252_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104100","volume":"89","author":"PP Abdalla","year":"2020","unstructured":"Abdalla PP, Dos Santos Carvalho A, Dos Santos AP, Venturini ACR, Alves TC, Mota J, et al. Cut-off points of knee extension strength allometrically adjusted to identify sarcopenia risk in older adults: a cross-sectional study. Arch Gerontol Geriatr. 2020;89:104100.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"1252_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-02935-7","volume":"37","author":"OO Hamalainen","year":"2025","unstructured":"Hamalainen OO, Savikangas TM, Tirkkonen AK, Alen MJ, Hautala AJ, Sipila S. Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial. Aging Clin Exp Res. 2025;37(1):36.","journal-title":"Aging Clin Exp Res"},{"issue":"7","key":"1252_CR34","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jgs.16517","volume":"68","author":"PM Cawthon","year":"2020","unstructured":"Cawthon PM, Manini T, Patel SM, Newman A, Travison T, Kiel DP, et al. Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc. 2020;68(7):1429\u201337.","journal-title":"J Am Geriatr Soc"},{"key":"1252_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clnesp.2022.12.006","volume":"53","author":"N Ohmae","year":"2023","unstructured":"Ohmae N, Yasui-Yamada S, Furumoto T, Wada K, Hayashi H, Kitao M, et al. Muscle mass, quality, and strength; physical function and activity; and metabolic status in cachectic patients with head and neck cancer. Clin Nutr ESPEN. 2023;53:113\u20139.","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"1252_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/wdev.230","volume":"5","author":"J Talbot","year":"2016","unstructured":"Talbot J, Maves L. Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. WIREs Dev Biol. 2016;5(4):518\u201334.","journal-title":"WIREs Dev Biol"},{"issue":"1","key":"1252_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13395-021-00279-0","volume":"11","author":"M Murgia","year":"2021","unstructured":"Murgia M, Nogara L, Baraldo M, Reggiani C, Mann M, Schiaffino S. Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study. Skelet Muscle. 2021;11(1):24.","journal-title":"Skelet Muscle"},{"issue":"1","key":"1252_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1152\/japplphysiol.00337.2023","volume":"136","author":"SS Blemker","year":"2024","unstructured":"Blemker SS, Brooks SV, Esser KA, Saul KR. Fiber-type traps: revisiting common misconceptions about skeletal muscle fiber types with application to motor control, biomechanics, physiology, and biology. J Appl Physiol (1985). 2024;136(1):109\u201321.","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"1252_CR39","first-page":"405","volume":"7","author":"E Volpi","year":"2004","unstructured":"Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7(4):405\u201310.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"1252_CR40","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1530\/JOE-16-0603","volume":"234","author":"P JafariNasabian","year":"2017","unstructured":"JafariNasabian P, Inglis JE, Reilly W, Kelly OJ, Ilich JZ. Aging human body: changes in bone, muscle and body fat with consequent changes in nutrient intake. J Endocrinol. 2017;234(1):R37\u201351.","journal-title":"J Endocrinol"},{"issue":"10","key":"1252_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","volume":"2","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819\u201329.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1252_CR42","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","volume":"61","author":"BH Goodpaster","year":"2006","unstructured":"Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1252_CR43","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/gerona\/glr070","volume":"66","author":"A Koster","year":"2011","unstructured":"Koster A, Ding J, Stenholm S, Caserotti P, Houston DK, Nicklas BJ, et al. Does the amount of fat mass predict age-related loss of lean mass, muscle strength, and muscle quality in older adults? J Gerontol A Biol Sci Med Sci. 2011;66(8):888\u201395.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1252_CR44","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/mus.880060809","volume":"6","author":"J Lexell","year":"1983","unstructured":"Lexell J, Henriksson-Larsen K, Winblad B, Sjostrom M. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve. 1983;6(8):588\u201395.","journal-title":"Muscle Nerve"},{"key":"1252_CR45","first-page":"11","volume":"50 Spec No","author":"J Lexell","year":"1995","unstructured":"Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci. 1995;50 Spec No:11\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2\u20133","key":"1252_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0022-510X(88)90132-3","volume":"84","author":"J Lexell","year":"1988","unstructured":"Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2\u20133):275\u201394.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1252_CR47","doi-asserted-by":"publisher","first-page":"B71","DOI":"10.1093\/geronj\/47.3.B71","volume":"47","author":"AR Coggan","year":"1992","unstructured":"Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth PM, et al. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol. 1992;47(3):B71\u20136.","journal-title":"J Gerontol"},{"issue":"1","key":"1252_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1034\/j.1600-0838.2003.00299.x","volume":"13","author":"JL Andersen","year":"2003","unstructured":"Andersen JL. Muscle fibre type adaptation in the elderly human muscle. Scand J Med Sci Sports. 2003;13(1):40\u20137.","journal-title":"Scand J Med Sci Sports"},{"issue":"5","key":"1252_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","volume":"48","author":"R Nilwik","year":"2013","unstructured":"Nilwik R, Snijders T, Leenders M, Groen BB, van Kranenburg J, Verdijk LB, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013;48(5):492\u20138.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1252_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1748-1716.1990.tb08974.x","volume":"140","author":"H Klitgaard","year":"1990","unstructured":"Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990;140(1):41\u201354.","journal-title":"Acta Physiol Scand"},{"issue":"5","key":"1252_CR51","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1249\/00005768-199405000-00006","volume":"26","author":"FW Booth","year":"1994","unstructured":"Booth FW, Weeden SH, Tseng BS. Effect of aging on human skeletal muscle and motor function. Med Sci Sports Exerc. 1994;26(5):556\u201360.","journal-title":"Med Sci Sports Exerc"},{"key":"1252_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101200","volume":"65","author":"P Wiedmer","year":"2021","unstructured":"Wiedmer P, Jung T, Castro JP, Pomatto LCD, Sun PY, Davies KJA, et al. Sarcopenia - molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1252_CR53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1152\/physrev.00031.2010","volume":"91","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91(4):1447\u2013531.","journal-title":"Physiol Rev"},{"issue":"2\u20133","key":"1252_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0022-510X(86)90009-2","volume":"72","author":"J Lexell","year":"1986","unstructured":"Lexell J, Downham D, Sjostrom M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in M. vastus lateralis from three groups of healthy men between 15 and 83 years. J Neurol Sci. 1986;72(2\u20133):211\u201322.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1252_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083618","volume":"9","author":"N Johns","year":"2014","unstructured":"Johns N, Hatakeyama S, Stephens NA, Degen M, Degen S, Frieauff W, et al. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS ONE. 2014;9(1):e83618.","journal-title":"PLoS ONE"},{"issue":"2","key":"1252_CR56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/jcsm.12007","volume":"6","author":"CM Op den Kamp","year":"2015","unstructured":"Op den Kamp CM, Gosker HR, Lagarde S, Tan DY, Snepvangers FJ, Dingemans AM, et al. Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia. J Cachexia Sarcopenia Muscle. 2015;6(2):164\u201373.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"1252_CR57","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.clnu.2016.02.016","volume":"35","author":"MJ Toth","year":"2016","unstructured":"Toth MJ, Callahan DM, Miller MS, Tourville TW, Hackett SB, Couch ME, et al. Skeletal muscle fiber size and fiber type distribution in human cancer: effects of weight loss and relationship to physical function. Clin Nutr. 2016;35(6):1359\u201365.","journal-title":"Clin Nutr"},{"key":"1252_CR58","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2014.11.006","volume":"79","author":"E Puig-Vilanova","year":"2015","unstructured":"Puig-Vilanova E, Rodriguez DA, Lloreta J, Ausin P, Pascual-Guardia S, Broquetas J, et al. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer. Free Radic Biol Med. 2015;79:91\u2013108.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1252_CR59","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-007-0177-2","volume":"85","author":"TL Schmitt","year":"2007","unstructured":"Schmitt TL, Martignoni ME, Bachmann J, Fechtner K, Friess H, Kinscherf R, et al. Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia. J Mol Med (Berl). 2007;85(6):647\u201354.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"1252_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jcmm.12165","volume":"18","author":"S Taskin","year":"2014","unstructured":"Taskin S, Stumpf VI, Bachmann J, Weber C, Martignoni ME, Friedrich O. Motor protein function in skeletal abdominal muscle of cachectic cancer patients. J Cell Mol Med. 2014;18(1):69\u201379.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1252_CR61","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1113\/jphysiol.1973.sp010369","volume":"234","author":"RE Burke","year":"1973","unstructured":"Burke RE, Levine DN, Tsairis P, Zajac FE 3rd. Physiological types and histochemical profiles in motor units of the cat gastrocnemius. J Physiol. 1973;234(3):723\u201348.","journal-title":"J Physiol"},{"key":"1252_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00293","volume":"8","author":"N Stifani","year":"2014","unstructured":"Stifani N. Motor neurons and the generation of spinal motor neuron diversity. Front Cell Neurosci. 2014;8:293.","journal-title":"Front Cell Neurosci"},{"key":"1252_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00208","volume":"6","author":"M Gonzalez-Freire","year":"2014","unstructured":"Gonzalez-Freire M, de Cabo R, Studenski SA, Ferrucci L. The neuromuscular junction: aging at the crossroad between nerves and muscle. Front Aging Neurosci. 2014;6:208.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1252_CR64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10522-015-9627-3","volume":"17","author":"M Piasecki","year":"2016","unstructured":"Piasecki M, Ireland A, Jones DA, McPhee JS. Age-dependent motor unit remodelling in human limb muscles. Biogerontology. 2016;17(3):485\u201396.","journal-title":"Biogerontology"},{"issue":"4","key":"1252_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00293457","volume":"81","author":"J Lexell","year":"1991","unstructured":"Lexell J, Downham DY. The occurrence of fibre-type grouping in healthy human muscle: a quantitative study of cross-sections of whole vastus lateralis from men between 15 and 83 years. Acta Neuropathol. 1991;81(4):377\u201381.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1252_CR66","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1113\/JP275520","volume":"596","author":"M Piasecki","year":"2018","unstructured":"Piasecki M, Ireland A, Piasecki J, Stashuk DW, Swiecicka A, Rutter MK, et al. Failure to expand the motor unit size to compensate for declining motor unit numbers distinguishes sarcopenic from non-sarcopenic older men. J Physiol. 2018;596(9):1627\u201337.","journal-title":"J Physiol"},{"issue":"1","key":"1252_CR67","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.4081\/bam.2014.1.5","volume":"24","author":"BM Carlson","year":"2014","unstructured":"Carlson BM. The biology of long-term denervated skeletal muscle. Eur J Transl Myol. 2014;24(1):3293.","journal-title":"Eur J Transl Myol"},{"key":"1252_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101966","volume":"89","author":"WD Arnold","year":"2023","unstructured":"Arnold WD, Clark BC. Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems. Ageing Res Rev. 2023;89:101966.","journal-title":"Ageing Res Rev"},{"issue":"8","key":"1252_CR69","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1113\/JP270561","volume":"594","author":"RT Hepple","year":"2016","unstructured":"Hepple RT, Rice CL. Innervation and neuromuscular control in ageing skeletal muscle. J Physiol. 2016;594(8):1965\u201378.","journal-title":"J Physiol"},{"issue":"4","key":"1252_CR70","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1152\/japplphysiol.00475.2016","volume":"121","author":"SK Hunter","year":"2016","unstructured":"Hunter SK, Pereira HM, Keenan KG. The aging neuromuscular system and motor performance. J Appl Physiol (1985). 2016;121(4):982\u201395.","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"1252_CR71","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/jcsm.13531","volume":"15","author":"F Sarto","year":"2024","unstructured":"Sarto F, Franchi MV, McPhee JS, Stashuk DW, Paganini M, Monti E, et al. Neuromuscular impairment at different stages of human sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15(5):1797\u2013810.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1252_CR72","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1152\/physrev.00033.2014","volume":"95","author":"LA Tintignac","year":"2015","unstructured":"Tintignac LA, Brenner HR, Ruegg MA. Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev. 2015;95(3):809\u201352.","journal-title":"Physiol Rev"},{"issue":"8","key":"1252_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114587","volume":"43","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Dos Santos M, Huang H, Chen K, Iyengar P, Infante R, et al. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution. Cell Rep. 2024;43(8):114587.","journal-title":"Cell Rep"},{"issue":"3","key":"1252_CR74","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/ijms21031092","volume":"21","author":"N Daou","year":"2020","unstructured":"Daou N, Hassani M, Matos E, De Castro GS, Costa RGF, Seelaender M, et al. Displaced myonuclei in cancer cachexia suggest altered innervation. Int J Mol Sci. 2020;21(3):1092.","journal-title":"Int J Mol Sci"},{"key":"1252_CR75","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9592","author":"R Sartori","year":"2021","unstructured":"Sartori R, Hagg A, Zampieri S, Armani A, Winbanks CE, Viana LR, et al. Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia. Sci Transl Med. 2021. https:\/\/doi.org\/10.1126\/scitranslmed.aay9592.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1252_CR76","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1172\/JCI128411","volume":"130","author":"I Boehm","year":"2020","unstructured":"Boehm I, Miller J, Wishart TM, Wigmore SJ, Skipworth RJ, Jones RA, et al. Neuromuscular junctions are stable in patients with cancer cachexia. J Clin Invest. 2020;130(3):1461\u20135.","journal-title":"J Clin Invest"},{"issue":"6","key":"1252_CR77","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijms20061451","volume":"20","author":"R Zajaczkowska","year":"2019","unstructured":"Zajaczkowska R, Kocot-Kepska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1252_CR78","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","volume":"20","author":"MS Hipp","year":"2019","unstructured":"Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1252_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147602","author":"DC Hughes","year":"2022","unstructured":"Hughes DC, Baehr LM, Waddell DS, Sharples AP, Bodine SC. Ubiquitin ligases in longevity and aging skeletal muscle. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23147602.","journal-title":"Int J Mol Sci"},{"key":"1252_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115147","volume":"165","author":"G Xie","year":"2023","unstructured":"Xie G, Jin H, Mikhail H, Pavel V, Yang G, Ji B, et al. Autophagy in sarcopenia: possible mechanisms and novel therapies. Biomed Pharmacother. 2023;165:115147.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1252_CR81","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","volume":"311","author":"PA Bilodeau","year":"2016","unstructured":"Bilodeau PA, Coyne ES, Wing SS. The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation. Am J Physiol Cell Physiol. 2016;311(3):C392-403.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"1252_CR82","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cmet.2009.10.008","volume":"10","author":"E Masiero","year":"2009","unstructured":"Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, et al. Autophagy is required to maintain muscle mass. Cell Metab. 2009;10(6):507\u201315.","journal-title":"Cell Metab"},{"issue":"6","key":"1252_CR83","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00424-005-1473-8","volume":"450","author":"SA Whitman","year":"2005","unstructured":"Whitman SA, Wacker MJ, Richmond SR, Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch. 2005;450(6):437\u201346.","journal-title":"Pflugers Arch"},{"issue":"7","key":"1252_CR84","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/gerona\/61.7.663","volume":"61","author":"E Edstrom","year":"2006","unstructured":"Edstrom E, Altun M, Hagglund M, Ulfhake B. Atrogin-1\/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61(7):663\u201374.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"1252_CR85","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.ajpath.2022.09.003","volume":"192","author":"K Chen","year":"2022","unstructured":"Chen K, Gao P, Li Z, Dai A, Yang M, Chen S, et al. Forkhead box O signaling pathway in skeletal muscle atrophy. Am J Pathol. 2022;192(12):1648\u201357.","journal-title":"Am J Pathol"},{"issue":"12","key":"1252_CR86","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/gerona\/62.12.1407","volume":"62","author":"U Raue","year":"2007","unstructured":"Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Proteolytic gene expression differs at rest and after resistance exercise between young and old women. J Gerontol A Biol Sci Med Sci. 2007;62(12):1407\u201312.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1252_CR87","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/gerona\/glu004","volume":"69","author":"MJ Drummond","year":"2014","unstructured":"Drummond MJ, Addison O, Brunker L, Hopkins PN, McClain DA, LaStayo PC, et al. Downregulation of E3 ubiquitin ligases and mitophagy-related genes in skeletal muscle of physically inactive, frail older women: a cross-sectional comparison. J Gerontol A Biol Sci Med Sci. 2014;69(8):1040\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"1252_CR88","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2014.07.061","volume":"8","author":"S Carnio","year":"2014","unstructured":"Carnio S, LoVerso F, Baraibar MA, Longa E, Khan MM, Maffei M, et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep. 2014;8(5):1509\u201321.","journal-title":"Cell Rep"},{"issue":"4","key":"1252_CR89","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11357-020-00208-x","volume":"42","author":"M Zampino","year":"2020","unstructured":"Zampino M, Brennan NA, Kuo PL, Spencer RG, Fishbein KW, Simonsick EM, et al. Poor mitochondrial health and systemic inflammation? Test of a classic hypothesis in the Baltimore Longitudinal Study of Aging. Geroscience. 2020;42(4):1175\u201382.","journal-title":"Geroscience"},{"key":"1252_CR90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bmb\/ldq008","volume":"95","author":"MV Narici","year":"2010","unstructured":"Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95:139\u201359.","journal-title":"Br Med Bull"},{"issue":"10","key":"1252_CR91","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.286.10.1206","volume":"286","author":"E Volpi","year":"2001","unstructured":"Volpi E, Sheffield-Moore M, Rasmussen BB, Wolfe RR. Basal muscle amino acid kinetics and protein synthesis in healthy young and older men. JAMA. 2001;286(10):1206\u201312.","journal-title":"JAMA"},{"issue":"5","key":"1252_CR92","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3945\/ajcn.2009.27543","volume":"90","author":"EA Wilkes","year":"2009","unstructured":"Wilkes EA, Selby AL, Atherton PJ, Patel R, Rankin D, Smith K, et al. Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. Am J Clin Nutr. 2009;90(5):1343\u201350.","journal-title":"Am J Clin Nutr"},{"issue":"26","key":"1252_CR93","doi-asserted-by":"publisher","first-page":"15364","DOI":"10.1073\/pnas.93.26.15364","volume":"93","author":"OE Rooyackers","year":"1996","unstructured":"Rooyackers OE, Adey DB, Ades PA, Nair KS. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci U S A. 1996;93(26):15364\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1252_CR94","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1096\/fj.08-117200","volume":"23","author":"GC Henderson","year":"2009","unstructured":"Henderson GC, Dhatariya K, Ford GC, Klaus KA, Basu R, Rizza RA, et al. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009;23(2):631\u201341.","journal-title":"FASEB J"},{"key":"1252_CR95","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/978-1-59259-963-9_50","volume-title":"Prin Mol Med","author":"WT Cade","year":"2006","unstructured":"Cade WT, Yarasheski KE. Metabolic and molecular aspects of sarcopenia. In: Runge MS, Patterson C, editors. Prin Mol Med. Totowa: Humana Press; 2006. p. 529\u201334."},{"issue":"12","key":"1252_CR96","first-page":"4481","volume":"85","author":"E Volpi","year":"2000","unstructured":"Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab. 2000;85(12):4481\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1252_CR97","doi-asserted-by":"publisher","first-page":"599S","DOI":"10.3945\/an.113.005405","volume":"5","author":"DR Moore","year":"2014","unstructured":"Moore DR. Keeping older muscle \u201cyoung\u201d through dietary protein and physical activity. Adv Nutr. 2014;5(5):599S-607S.","journal-title":"Adv Nutr"},{"issue":"3","key":"1252_CR98","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.arr.2011.11.001","volume":"11","author":"BA Irving","year":"2012","unstructured":"Irving BA, Robinson MM, Nair KS. Age effect on myocellular remodeling: response to exercise and nutrition in humans. Ageing Res Rev. 2012;11(3):374\u201389.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"1252_CR99","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbadis.2008.10.011","volume":"1782","author":"AJ Murton","year":"2008","unstructured":"Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta. 2008;1782(12):730\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1252_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun. 2021;12(1):330.","journal-title":"Nat Commun"},{"issue":"1","key":"1252_CR101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16(1):54.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1252_CR102","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3892\/or.2015.3845","volume":"33","author":"L Yuan","year":"2015","unstructured":"Yuan L, Han J, Meng Q, Xi Q, Zhuang Q, Jiang Y, et al. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Oncol Rep. 2015;33(5):2261\u20138.","journal-title":"Oncol Rep"},{"issue":"3","key":"1252_CR103","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/ajcn\/nqz347","volume":"111","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang J, Wang X, Gao T, Tian H, Zhou D, et al. The autophagic-lysosomal and ubiquitin proteasome systems are simultaneously activated in the skeletal muscle of gastric cancer patients with cachexia. Am J Clin Nutr. 2020;111(3):570\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1252_CR104","first-page":"257","volume":"14","author":"CH DeJong","year":"2005","unstructured":"DeJong CH, Busquets S, Moses AG, Schrauwen P, Ross JA, Argiles JM, et al. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia. Oncol Rep. 2005;14(1):257\u201363.","journal-title":"Oncol Rep"},{"issue":"3","key":"1252_CR105","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/01.SLA.0000055225.96357.71","volume":"237","author":"M Bossola","year":"2003","unstructured":"Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, et al. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg. 2003;237(3):384\u20139.","journal-title":"Ann Surg"},{"issue":"10","key":"1252_CR106","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-11-2133","volume":"18","author":"IJ Gallagher","year":"2012","unstructured":"Gallagher IJ, Stephens NA, MacDonald AJ, Skipworth RJ, Husi H, Greig CA, et al. Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin Cancer Res. 2012;18(10):2817\u201327.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1252_CR107","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3945\/ajcn.113.058388","volume":"98","author":"CM Op den Kamp","year":"2013","unstructured":"Op den Kamp CM, Langen RC, Snepvangers FJ, de Theije CC, Schellekens JM, Laugs F, et al. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr. 2013;98(3):738\u201348.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1252_CR108","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mus.21893","volume":"43","author":"IJ Smith","year":"2011","unstructured":"Smith IJ, Aversa Z, Hasselgren PO, Pacelli F, Rosa F, Doglietto GB, et al. Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss. Muscle Nerve. 2011;43(3):410\u20134.","journal-title":"Muscle Nerve"},{"issue":"6","key":"1252_CR109","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3945\/ajcn.113.063859","volume":"98","author":"N Tardif","year":"2013","unstructured":"Tardif N, Klaude M, Lundell L, Thorell A, Rooyackers O. Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients. Am J Clin Nutr. 2013;98(6):1485\u201392.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1252_CR110","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/cs1020353","volume":"102","author":"RT Jagoe","year":"2002","unstructured":"Jagoe RT, Redfern CP, Roberts RG, Gibson GJ, Goodship TH. Skeletal muscle mrna levels for cathepsin B, but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoracotomy. Clin Sci (Lond). 2002;102(3):353\u201361.","journal-title":"Clin Sci (Lond)"},{"key":"1252_CR111","doi-asserted-by":"publisher","first-page":"30340","DOI":"10.1038\/srep30340","volume":"6","author":"Z Aversa","year":"2016","unstructured":"Aversa Z, Pin F, Lucia S, Penna F, Verzaro R, Fazi M, et al. Autophagy is induced in the skeletal muscle of cachectic cancer patients. Sci Rep. 2016;6:30340.","journal-title":"Sci Rep"},{"issue":"9","key":"1252_CR112","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/cancers11091264","volume":"11","author":"GS de Castro","year":"2019","unstructured":"de Castro GS, Simoes E, Lima J, Ortiz-Silva M, Festuccia WT, Tokeshi F, et al. Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle. Cancers (Basel). 2019;11(9):1264.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"1252_CR113","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jcsm.13073","volume":"14","author":"A Martin","year":"2023","unstructured":"Martin A, Gallot YS, Freyssenet D. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. J Cachexia Sarcopenia Muscle. 2023;14(3):1150\u201367.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1252_CR114","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M","volume":"82","author":"F Dworzak","year":"1998","unstructured":"Dworzak F, Ferrari P, Gavazzi C, Maiorana C, Bozzetti F. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover. Cancer. 1998;82(1):42\u20138.","journal-title":"Cancer"},{"issue":"6445","key":"1252_CR115","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/bmj.289.6445.584","volume":"289","author":"PW Emery","year":"1984","unstructured":"Emery PW, Edwards RH, Rennie MJ, Souhami RL, Halliday D. Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed). 1984;289(6445):584\u20136.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"1252_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1249\/JES.0000000000000101","volume":"45","author":"SE Alway","year":"2017","unstructured":"Alway SE, Mohamed JS, Myers MJ. Mitochondria initiate and regulate sarcopenia. Exerc Sport Sci Rev. 2017;45(2):58\u201369.","journal-title":"Exerc Sport Sci Rev"},{"issue":"1","key":"1252_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24956-2","volume":"12","author":"L Grevendonk","year":"2021","unstructured":"Grevendonk L, Connell NJ, McCrum C, Fealy CE, Bilet L, Bruls YMH, et al. Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function. Nat Commun. 2021;12(1):4773.","journal-title":"Nat Commun"},{"key":"1252_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11070424","author":"A Michelucci","year":"2021","unstructured":"Michelucci A, Liang C, Protasi F, Dirksen RT. Altered Ca(2+) handling and oxidative stress underlie mitochondrial damage and skeletal muscle dysfunction in aging and disease. Metabolites. 2021. https:\/\/doi.org\/10.3390\/metabo11070424.","journal-title":"Metabolites"},{"key":"1252_CR119","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.2002.tb02094.x","volume":"959","author":"G Lenaz","year":"2002","unstructured":"Lenaz G, Bovina C, D\u2019Aurelio M, Fato R, Formiggini G, Genova ML, et al. Role of mitochondria in oxidative stress and aging. Ann N Y Acad Sci. 2002;959:199\u2013213.","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"1252_CR120","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jshs.2020.01.001","volume":"9","author":"LL Ji","year":"2020","unstructured":"Ji LL, Yeo D, Kang C, Zhang T. The role of mitochondria in redox signaling of muscle homeostasis. J Sport Health Sci. 2020;9(5):386\u201393.","journal-title":"J Sport Health Sci"},{"key":"1252_CR121","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcdb.2022.01.011","volume":"143","author":"FA Rahman","year":"2023","unstructured":"Rahman FA, Quadrilatero J. Mitochondrial apoptotic signaling involvement in remodeling during myogenesis and skeletal muscle atrophy. Semin Cell Dev Biol. 2023;143:66\u201374.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1252_CR122","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/db09-0591","volume":"59","author":"H Karakelides","year":"2010","unstructured":"Karakelides H, Irving BA, Short KR, O\u2019Brien P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59(1):89\u201397.","journal-title":"Diabetes"},{"issue":"Pt 1","key":"1252_CR123","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1469-7793.2000.t01-1-00203.x","volume":"526 Pt 1","author":"KE Conley","year":"2000","unstructured":"Conley KE, Jubrias SA, Esselman PC. Oxidative capacity and ageing in human muscle. J Physiol. 2000;526 Pt 1(Pt 1):203\u201310.","journal-title":"J Physiol"},{"issue":"2","key":"1252_CR124","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/gerona\/glu007","volume":"70","author":"MR Beltran Valls","year":"2015","unstructured":"Beltran Valls MR, Wilkinson DJ, Narici MV, Smith K, Phillips BE, Caporossi D, et al. Protein carbonylation and heat shock proteins in human skeletal muscle: relationships to age and sarcopenia. J Gerontol A Biol Sci Med Sci. 2015;70(2):174\u201381.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"1252_CR125","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/gerona\/gls196","volume":"68","author":"PM Coen","year":"2013","unstructured":"Coen PM, Jubrias SA, Distefano G, Amati F, Mackey DC, Glynn NW, et al. Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. J Gerontol A Biol Sci Med Sci. 2013;68(4):447\u201355.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1252_CR126","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11357-024-01373-z","volume":"47","author":"EL Gay","year":"2024","unstructured":"Gay EL, Coen PM, Harrison S, Garcia RE, Qiao YS, Goodpaster BH, et al. Sex differences in the association between skeletal muscle energetics and perceived physical fatigability: the Study of Muscle, Mobility and Aging (SOMMA). Geroscience. 2024;47:1999\u20132013.","journal-title":"Geroscience."},{"issue":"6","key":"1252_CR127","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100067R","volume":"35","author":"M Adebayo","year":"2021","unstructured":"Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. FASEB J. 2021;35(6):e21620.","journal-title":"FASEB J"},{"issue":"16","key":"1252_CR128","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1113\/JP271212","volume":"594","author":"KA Rygiel","year":"2016","unstructured":"Rygiel KA, Picard M, Turnbull DM. The ageing neuromuscular system and sarcopenia: a mitochondrial perspective. J Physiol. 2016;594(16):4499\u2013512.","journal-title":"J Physiol"},{"issue":"1","key":"1252_CR129","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18632\/aging.101358","volume":"10","author":"A Del Campo","year":"2018","unstructured":"Del Campo A, Contreras-Hernandez I, Castro-Sepulveda M, Campos CA, Figueroa R, Tevy MF, et al. Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice. Aging (Albany NY). 2018;10(1):34\u201355.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"1252_CR130","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/MCB.01036-12","volume":"33","author":"C Ibebunjo","year":"2013","unstructured":"Ibebunjo C, Chick JM, Kendall T, Eash JK, Li C, Zhang Y, et al. Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol. 2013;33(2):194\u2013212.","journal-title":"Mol Cell Biol"},{"key":"1252_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113150","author":"M Beltra","year":"2021","unstructured":"Beltra M, Pin F, Ballaro R, Costelli P, Penna F. Mitochondrial dysfunction in cancer cachexia: impact on muscle health and regeneration. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10113150.","journal-title":"Cells"},{"issue":"2","key":"1252_CR132","first-page":"137","volume":"1870","author":"M van der Ende","year":"2018","unstructured":"van der Ende M, Grefte S, Plas R, Meijerink J, Witkamp RF, Keijer J, et al. Mitochondrial dynamics in cancer-induced cachexia. Biochimica et Biophysica Acta (BBA). 2018;1870(2):137\u201350.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"6","key":"1252_CR133","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.3892\/mmr.2020.11608","volume":"22","author":"W Yang","year":"2020","unstructured":"Yang W, Huang J, Wu H, Wang Y, Du Z, Ling Y, et al. Molecular mechanisms of cancer cachexia-induced muscle atrophy (review). Mol Med Rep. 2020;22(6):4967\u201380.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1252_CR134","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10974-019-09510-4","volume":"40","author":"D Neyroud","year":"2019","unstructured":"Neyroud D, Nosacka RL, Judge AR, Hepple RT. Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content. J Muscle Res Cell Motil. 2019;40(1):59\u201365.","journal-title":"J Muscle Res Cell Motil"},{"issue":"3","key":"1252_CR135","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","volume":"1830","author":"CC Fontes-Oliveira","year":"2013","unstructured":"Fontes-Oliveira CC, Busquets S, Toledo M, Penna F, Paz Aylwin M, Sirisi S, et al. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim Biophys Acta. 2013;1830(3):2770\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1252_CR136","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.18632\/aging.101006","volume":"8","author":"J Brzeszczynska","year":"2016","unstructured":"Brzeszczynska J, Johns N, Schilb A, Degen S, Degen M, Langen R, et al. Loss of oxidative defense and potential blockade of satellite cell maturation in the skeletal muscle of patients with cancer but not in the healthy elderly. Aging (Albany NY). 2016;8(8):1690\u2013702.","journal-title":"Aging (Albany NY)."},{"key":"1252_CR137","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2024.11.046","volume":"227","author":"H Xu","year":"2025","unstructured":"Xu H, Brown JL, Bhaskaran S, Van Remmen H. Reactive oxygen species in the pathogenesis of sarcopenia. Free Radic Biol Med. 2025;227:446\u201358.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1252_CR138","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev. 2013;93(1):23\u201367.","journal-title":"Physiol Rev"},{"issue":"12","key":"1252_CR139","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1249\/MSS.0b013e3182667c2e","volume":"44","author":"LB Verdijk","year":"2012","unstructured":"Verdijk LB, Dirks ML, Snijders T, Prompers JJ, Beelen M, Jonkers RA, et al. Reduced satellite cell numbers with spinal cord injury and aging in humans. Med Sci Sports Exerc. 2012;44(12):2322\u201330.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"1252_CR140","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11357-013-9583-2","volume":"36","author":"LB Verdijk","year":"2014","unstructured":"Verdijk LB, Snijders T, Drost M, Delhaas T, Kadi F, van Loon LJ. Satellite cells in human skeletal muscle; from birth to old age. Age (Dordr). 2014;36(2):545\u20137.","journal-title":"Age (Dordr)"},{"issue":"Pt 20","key":"1252_CR141","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1242\/jcs.02602","volume":"118","author":"AS Brack","year":"2005","unstructured":"Brack AS, Bildsoe H, Hughes SM. Evidence that satellite cell decrement contributes to preferential decline in nuclear number from large fibres during murine age-related muscle atrophy. J Cell Sci. 2005;118(Pt 20):4813\u201321.","journal-title":"J Cell Sci"},{"key":"1252_CR142","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1101\/sqb.2011.76.010652","volume":"76","author":"YC Jang","year":"2011","unstructured":"Jang YC, Sinha M, Cerletti M, Dall\u2019Osso C, Wagers AJ. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Cold Spring Harb Symp Quant Biol. 2011;76:101\u201311.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"7488","key":"1252_CR143","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature13013","volume":"506","author":"P Sousa-Victor","year":"2014","unstructured":"Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V, et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 2014;506(7488):316\u201321.","journal-title":"Nature"},{"issue":"11","key":"1252_CR144","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1172\/JCI68523","volume":"123","author":"WA He","year":"2013","unstructured":"He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J, et al. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013;123(11):4821\u201335.","journal-title":"J Clin Invest"},{"issue":"10","key":"1252_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205467","volume":"13","author":"S Inaba","year":"2018","unstructured":"Inaba S, Hinohara A, Tachibana M, Tsujikawa K, Fukada SI. Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential. PLoS ONE. 2018;13(10):e0205467.","journal-title":"PLoS ONE"},{"issue":"10","key":"1252_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013604","volume":"5","author":"F Penna","year":"2010","unstructured":"Penna F, Costamagna D, Fanzani A, Bonelli G, Baccino FM, Costelli P. Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS ONE. 2010;5(10):e13604.","journal-title":"PLoS ONE"},{"issue":"10","key":"1252_CR147","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","volume":"86","author":"H Li","year":"2008","unstructured":"Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl). 2008;86(10):1113\u201326.","journal-title":"J Mol Med (Berl)"},{"key":"1252_CR148","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.arr.2017.09.001","volume":"40","author":"PC Calder","year":"2017","unstructured":"Calder PC, Bosco N, Bourdet-Sicard R, Capuron L, Delzenne N, Dore J, et al. Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev. 2017;40:95\u2013119.","journal-title":"Ageing Res Rev"},{"issue":"12","key":"1252_CR149","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","volume":"14","author":"M Michaud","year":"2013","unstructured":"Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14(12):877\u201382.","journal-title":"J Am Med Dir Assoc"},{"key":"1252_CR150","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jot.2017.05.006","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Leung KS, Chow SK, Cheung WH. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Translat. 2017;10:94\u2013101.","journal-title":"J Orthop Translat"},{"issue":"1","key":"1252_CR151","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12603-013-0336-9","volume":"18","author":"JL Atkins","year":"2014","unstructured":"Atkins JL, Whincup PH, Morris RW, Wannamethee SG. Low muscle mass in older men: the role of lifestyle, diet and cardiovascular risk factors. J Nutr Health Aging. 2014;18(1):26\u201333.","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"1252_CR152","doi-asserted-by":"publisher","first-page":"526e9\u201317","DOI":"10.1016\/j.amjmed.2005.10.049","volume":"119","author":"LA Schaap","year":"2006","unstructured":"Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526e9-17.","journal-title":"Am J Med"},{"issue":"22","key":"1252_CR153","doi-asserted-by":"publisher","first-page":"13471","DOI":"10.18632\/aging.205254","volume":"15","author":"KV Chang","year":"2023","unstructured":"Chang KV, Wu WT, Chen YH, Chen LR, Hsu WH, Lin YL, et al. Enhanced serum levels of tumor necrosis factor-alpha, interleukin-1beta, and -6 in sarcopenia: alleviation through exercise and nutrition intervention. Aging (Albany NY). 2023;15(22):13471\u201385.","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"1252_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-1007-9","volume":"18","author":"YD Rong","year":"2018","unstructured":"Rong YD, Bian AL, Hu HY, Ma Y, Zhou XZ. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18(1):308.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1252_CR155","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1172\/JCI118398","volume":"97","author":"T Tsujinaka","year":"1996","unstructured":"Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, et al. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest. 1996;97(1):244\u20139.","journal-title":"J Clin Invest"},{"issue":"11","key":"1252_CR156","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/gerona\/glp097","volume":"64","author":"LA Schaap","year":"2009","unstructured":"Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64(11):1183\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1252_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"L Barnabei","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R. NF-kappaB: at the borders of autoimmunity and inflammation. Front Immunol. 2021;12:716469.","journal-title":"Front Immunol"},{"issue":"2","key":"1252_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, et al. IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004;119(2):285\u201398.","journal-title":"Cell"},{"issue":"11","key":"1252_CR159","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1172\/JCI28721","volume":"116","author":"F Mourkioti","year":"2006","unstructured":"Mourkioti F, Kratsios P, Luedde T, Song YH, Delafontaine P, Adami R, et al. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest. 2006;116(11):2945\u201354.","journal-title":"J Clin Invest"},{"issue":"2","key":"1252_CR160","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16(2):153\u201366.","journal-title":"Cell Metab"},{"issue":"3","key":"1252_CR161","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","volume":"127","author":"J McGovern","year":"2022","unstructured":"McGovern J, Dolan RD, Skipworth RJ, Laird BJ, McMillan DC. Cancer cachexia: a nutritional or a systemic inflammatory syndrome? Br J Cancer. 2022;127(3):379\u201382.","journal-title":"Br J Cancer"},{"key":"1252_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.597675","volume":"11","author":"JM Webster","year":"2020","unstructured":"Webster JM, Kempen L, Hardy RS, Langen RCJ. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. 2020;11:597675.","journal-title":"Front Physiol"},{"key":"1252_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091304","author":"T Abbass","year":"2019","unstructured":"Abbass T, Dolan RD, Laird BJ, McMillan DC. The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: a systematic review. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11091304.","journal-title":"Cancers (Basel)"},{"key":"1252_CR164","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","volume":"170","author":"HJ Patel","year":"2017","unstructured":"Patel HJ, Patel BM. TNF-alpha and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56\u201363.","journal-title":"Life Sci"},{"issue":"5","key":"1252_CR165","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","volume":"457","author":"KA Baltgalvis","year":"2009","unstructured":"Baltgalvis KA, Berger FG, Pena MM, Davis JM, White JP, Carson JA. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min\/+ ) mouse. Pflugers Arch. 2009;457(5):989\u20131001.","journal-title":"Pflugers Arch"},{"issue":"2","key":"1252_CR166","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcsm.12912","volume":"13","author":"DR Paval","year":"2022","unstructured":"Paval DR, Patton R, McDonald J, Skipworth RJE, Gallagher IJ, Laird BJ. A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle. 2022;13(2):824\u201338.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1252_CR167","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnut.2020.00004","volume":"7","author":"D Riccardi","year":"2020","unstructured":"Riccardi D, das Neves RX, de Matos-Neto EM, Camargo RG, Lima J, Radloff K, et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front Nutr. 2020;7:4.","journal-title":"Front Nutr"},{"issue":"6","key":"1252_CR168","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.clnu.2007.07.004","volume":"26","author":"EL Dillon","year":"2007","unstructured":"Dillon EL, Volpi E, Wolfe RR, Sinha S, Sanford AP, Arrastia CD, et al. Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy. Clin Nutr. 2007;26(6):736\u201343.","journal-title":"Clin Nutr"},{"issue":"1","key":"1252_CR169","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cllc.2016.06.003","volume":"18","author":"AJ Murton","year":"2017","unstructured":"Murton AJ, Maddocks M, Stephens FB, Marimuthu K, England R, Wilcock A. Consequences of late-stage non-small-cell lung cancer cachexia on muscle metabolic processes. Clin Lung Cancer. 2017;18(1):e1\u201311.","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"1252_CR170","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1172\/JCI200420174","volume":"114","author":"S Acharyya","year":"2004","unstructured":"Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004;114(3):370\u20138.","journal-title":"J Clin Invest"},{"issue":"5488","key":"1252_CR171","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"DC Guttridge","year":"2000","unstructured":"Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000;289(5488):2363\u20136.","journal-title":"Science"},{"issue":"4","key":"1252_CR172","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1074\/jbc.M207129200","volume":"278","author":"KJ Ladner","year":"2003","unstructured":"Ladner KJ, Caligiuri MA, Guttridge DC. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem. 2003;278(4):2294\u2013303.","journal-title":"J Biol Chem"},{"issue":"4","key":"1252_CR173","doi-asserted-by":"publisher","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","volume":"279","author":"YP Li","year":"2000","unstructured":"Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol. 2000;279(4):R1165\u201370.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"1252_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114925","volume":"43","author":"BR Pryce","year":"2024","unstructured":"Pryce BR, Oles A, Talbert EE, Romeo MJ, Vaena S, Sharma S, et al. Muscle inflammation is regulated by NF-kappaB from multiple cells to control distinct states of wasting in cancer cachexia. Cell Rep. 2024;43(11):114925.","journal-title":"Cell Rep"},{"issue":"1","key":"1252_CR175","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/rco2.56","volume":"5","author":"CM Fairman","year":"2022","unstructured":"Fairman CM, Lonbro S, Cardaci TD, VanderVeen BN, Nilsen TS, Murphy AE. Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials. JCSM Rapid Commun. 2022;5(1):52\u201367.","journal-title":"JCSM Rapid Commun"},{"key":"1252_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102589","volume":"102","author":"G Chinvattanachot","year":"2024","unstructured":"Chinvattanachot G, Rivas D, Duque G. Mechanisms of muscle cells alterations and regeneration decline during aging. Ageing Res Rev. 2024;102:102589.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"1252_CR177","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1532-5415.1997.tb04497.x","volume":"45","author":"TB Harris","year":"1997","unstructured":"Harris TB, Kiel D, Roubenoff R, Langlois J, Hannan M, Havlik R, et al. Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. J Am Geriatr Soc. 1997;45(2):133\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1252_CR178","doi-asserted-by":"publisher","first-page":"M176","DOI":"10.1093\/gerona\/53A.3.M176","volume":"53","author":"KG O'Connor","year":"1998","unstructured":"O\u2019Connor KG, Tobin JD, Harman SM, Plato CC, Roy TA, Sherman SS, et al. Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol A Biol Sci Med Sci. 1998;53(3):M176\u201382.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1252_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073535","author":"B Barone","year":"2022","unstructured":"Barone B, Napolitano L, Abate M, Cirillo L, Reccia P, Passaro F, et al. The role of testosterone in the elderly: what do we know? Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23073535.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1252_CR180","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.maturitas.2011.01.014","volume":"68","author":"V Messier","year":"2011","unstructured":"Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis AD, Aubertin-Leheudre M. Menopause and sarcopenia: a potential role for sex hormones. Maturitas. 2011;68(4):331\u20136.","journal-title":"Maturitas"},{"key":"1252_CR181","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1479-5876-10-224","volume":"10","author":"JE Puche","year":"2012","unstructured":"Puche JE, Castilla-Cortazar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med. 2012;10:224.","journal-title":"J Transl Med"},{"issue":"8","key":"1252_CR182","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1471-4914(03)00138-2","volume":"9","author":"DJ Glass","year":"2003","unstructured":"Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med. 2003;9(8):344\u201350.","journal-title":"Trends Mol Med"},{"key":"1252_CR183","first-page":"267","volume":"346","author":"DJ Glass","year":"2010","unstructured":"Glass DJ. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr Top Microbiol Immunol. 2010;346:267\u201378.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1252_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091970","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9091970.","journal-title":"Cells"},{"issue":"11","key":"1252_CR185","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3(11):1014\u20139.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1252_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03236-y","volume":"21","author":"A Bian","year":"2020","unstructured":"Bian A, Ma Y, Zhou X, Guo Y, Wang W, Zhang Y, et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet Disord. 2020;21(1):214.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"1252_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04699-3","volume":"22","author":"S Jarmusch","year":"2021","unstructured":"Jarmusch S, Baber L, Bidlingmaier M, Ferrari U, Hofmeister F, Hintze S, et al. Influence of IGF-I serum concentration on muscular regeneration capacity in patients with sarcopenia. BMC Musculoskelet Disord. 2021;22(1):807.","journal-title":"BMC Musculoskelet Disord"},{"key":"1252_CR188","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jsbmb.2013.05.005","volume":"138","author":"CS Deane","year":"2013","unstructured":"Deane CS, Hughes DC, Sculthorpe N, Lewis MP, Stewart CE, Sharples AP. Impaired hypertrophy in myoblasts is improved with testosterone administration. J Steroid Biochem Mol Biol. 2013;138:152\u201361.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"1252_CR189","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/bjp.2008.118","volume":"154","author":"F Kadi","year":"2008","unstructured":"Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol. 2008;154(3):522\u20138.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1252_CR190","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1210\/jc.2006-0357","volume":"91","author":"I Sinha-Hikim","year":"2006","unstructured":"Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab. 2006;91(8):3024\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1252_CR191","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.1152\/ajpendo.00370.2002","volume":"285","author":"I Sinha-Hikim","year":"2003","unstructured":"Sinha-Hikim I, Roth SM, Lee MI, Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab. 2003;285(1):E197-205.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1252_CR192","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.mce.2012.10.019","volume":"365","author":"JP White","year":"2013","unstructured":"White JP, Gao S, Puppa MJ, Sato S, Welle SL, Carson JA. Testosterone regulation of Akt\/mTORC1\/FoxO3a signaling in skeletal muscle. Mol Cell Endocrinol. 2013;365(2):174\u201386.","journal-title":"Mol Cell Endocrinol"},{"key":"1252_CR193","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.steroids.2016.08.009","volume":"115","author":"JG Mouser","year":"2016","unstructured":"Mouser JG, Loprinzi PD, Loenneke JP. The association between physiologic testosterone levels, lean mass, and fat mass in a nationally representative sample of men in the United States. Steroids. 2016;115:62\u20136.","journal-title":"Steroids"},{"issue":"8","key":"1252_CR194","first-page":"2670","volume":"85","author":"PJ Snyder","year":"2000","unstructured":"Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2670\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1252_CR195","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1210\/jc.2003-032006","volume":"89","author":"C Wang","year":"2004","unstructured":"Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004;89(5):2085\u201398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1252_CR196","first-page":"2839","volume":"85","author":"C Wang","year":"2000","unstructured":"Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2839\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"1252_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.682012","volume":"12","author":"A Geraci","year":"2021","unstructured":"Geraci A, Calvani R, Ferri E, Marzetti E, Arosio B, Cesari M. Sarcopenia and menopause: the role of estradiol. Front Endocrinol (Lausanne). 2021;12:682012.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Pt B","key":"1252_CR198","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.arr.2015.07.011","volume":"24","author":"A La Colla","year":"2015","unstructured":"La Colla A, Pronsato L, Milanesi L, Vasconsuelo A. 17beta-estradiol and testosterone in sarcopenia: role of satellite cells. Ageing Res Rev. 2015;24(Pt B):166\u201377.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"1252_CR199","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.celrep.2019.06.025","volume":"28","author":"BC Collins","year":"2019","unstructured":"Collins BC, Arpke RW, Larson AA, Baumann CW, Xie N, Cabelka CA, et al. Estrogen regulates the satellite cell compartment in females. Cell Rep. 2019;28(2):368-81e6.","journal-title":"Cell Rep"},{"key":"1252_CR200","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2019.03.033","volume":"123","author":"BC Collins","year":"2019","unstructured":"Collins BC, Laakkonen EK, Lowe DA. Aging of the musculoskeletal system: how the loss of estrogen impacts muscle strength. Bone. 2019;123:137\u201344.","journal-title":"Bone"},{"issue":"23","key":"1252_CR201","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.3748\/wjg.14.3633","volume":"14","author":"M Kerem","year":"2008","unstructured":"Kerem M, Ferahkose Z, Yilmaz UT, Pasaoglu H, Ofluoglu E, Bedirli A, et al. Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol. 2008;14(23):3633\u201341.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1252_CR202","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1042\/cs0970215","volume":"97","author":"JP Simons","year":"1999","unstructured":"Simons JP, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999;97(2):215\u201323.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"1252_CR203","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/mus.23798","volume":"48","author":"A Bonetto","year":"2013","unstructured":"Bonetto A, Penna F, Aversa Z, Mercantini P, Baccino FM, Costelli P, et al. Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patients. Muscle Nerve. 2013;48(3):387\u201392.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1252_CR204","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00002371-199603000-00007","volume":"19","author":"BD Curti","year":"1996","unstructured":"Curti BD, Urba WJ, Longo DL, Janik JE, Sharfman WH, Miller LL, et al. Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer. J Immunother Emphasis Tumor Immunol. 1996;19(2):142\u20138.","journal-title":"J Immunother Emphasis Tumor Immunol"},{"issue":"6","key":"1252_CR205","first-page":"1690","volume":"77","author":"G Mastorakos","year":"1993","unstructured":"Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993;77(6):1690\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1252_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","volume":"79","author":"AV Turnbull","year":"1999","unstructured":"Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev. 1999;79(1):1\u201371.","journal-title":"Physiol Rev"},{"key":"1252_CR207","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.692142","volume":"11","author":"AER Kartikasari","year":"2021","unstructured":"Kartikasari AER, Huertas CS, Mitchell A, Plebanski M. Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front Oncol. 2021;11:692142.","journal-title":"Front Oncol"},{"issue":"1","key":"1252_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01898-3","volume":"26","author":"A Lindholm","year":"2024","unstructured":"Lindholm A, Abrahamsen ML, Buch-Larsen K, Marina D, Andersson M, Helge JW, et al. Pro-inflammatory cytokines increase temporarily after adjuvant treatment for breast cancer in postmenopausal women: a longitudinal study. Breast Cancer Res. 2024;26(1):142.","journal-title":"Breast Cancer Res"},{"key":"1252_CR209","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/OTT.S60114","volume":"7","author":"D Vyas","year":"2014","unstructured":"Vyas D, Laput G, Vyas AK. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis. Onco Targets Ther. 2014;7:1015\u201323.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1252_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190958","volume":"13","author":"MP Cala","year":"2018","unstructured":"Cala MP, Aldana J, Medina J, Sanchez J, Guio J, Wist J, et al. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: a pilot control-case study in Colombian Hispanic women. PLoS ONE. 2018;13(2):e0190958.","journal-title":"PLoS ONE"},{"issue":"5","key":"1252_CR211","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.cmet.2016.10.010","volume":"24","author":"TR Flint","year":"2016","unstructured":"Flint TR, Janowitz T, Connell CM, Roberts EW, Denton AE, Coll AP, et al. Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity. Cell Metab. 2016;24(5):672\u201384.","journal-title":"Cell Metab"},{"issue":"Pt 5","key":"1252_CR212","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/000456329102800510","volume":"28","author":"ML Knapp","year":"1991","unstructured":"Knapp ML, al-Sheibani S, Riches PG, Hanham IW, Phillips RH. Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem. 1991;28(Pt 5):480\u20136.","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"1252_CR213","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1210\/clinem\/dgab862","volume":"107","author":"S Katsuhara","year":"2022","unstructured":"Katsuhara S, Yokomoto-Umakoshi M, Umakoshi H, Matsuda Y, Iwahashi N, Kaneko H, et al. Impact of cortisol on reduction in muscle strength and mass: a Mendelian randomization study. J Clin Endocrinol Metab. 2022;107(4):e1477\u201387.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1252_CR214","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2265.2008.03212.x","volume":"69","author":"GM Peeters","year":"2008","unstructured":"Peeters GM, van Schoor NM, van Rossum EF, Visser M, Lips P. The relationship between cortisol, muscle mass and muscle strength in older persons and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol (Oxf). 2008;69(4):673\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"1252_CR215","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106489","volume":"9","author":"TP Braun","year":"2014","unstructured":"Braun TP, Szumowski M, Levasseur PR, Grossberg AJ, Zhu X, Agarwal A, et al. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle. PLoS ONE. 2014;9(9):e106489.","journal-title":"PLoS ONE"},{"issue":"2","key":"1252_CR216","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/jappl.1995.78.2.629","volume":"78","author":"PN Dekhuijzen","year":"1995","unstructured":"Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R, Decramer M. Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J Appl Physiol. 1995;78(2):629\u201337.","journal-title":"J Appl Physiol"},{"issue":"10","key":"1252_CR217","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","volume":"45","author":"O Schakman","year":"2013","unstructured":"Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol. 2013;45(10):2163\u201372.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"1252_CR218","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","volume":"32","author":"E Lofberg","year":"2002","unstructured":"Lofberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, et al. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest. 2002;32(5):345\u201353.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"1252_CR219","first-page":"2136","volume":"86","author":"Z Liu","year":"2001","unstructured":"Liu Z, Jahn LA, Long W, Fryburg DA, Wei L, Barrett EJ. Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action. J Clin Endocrinol Metab. 2001;86(5):2136\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1252_CR220","first-page":"201","volume":"2","author":"PO Hasselgren","year":"1999","unstructured":"Hasselgren PO. Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care. 1999;2(3):201\u20135.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"1252_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052363","volume":"7","author":"JK Jellyman","year":"2012","unstructured":"Jellyman JK, Martin-Gronert MS, Cripps RL, Giussani DA, Ozanne SE, Shen QW, et al. Effects of cortisol and dexamethasone on insulin signalling pathways in skeletal muscle of the ovine fetus during late gestation. PLoS ONE. 2012;7(12):e52363.","journal-title":"PLoS ONE"},{"issue":"1","key":"1252_CR222","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1677\/joe.0.1560083","volume":"156","author":"D Dardevet","year":"1998","unstructured":"Dardevet D, Sornet C, Savary I, Debras E, Patureau-Mirand P, Grizard J. Glucocorticoid effects on insulin- and IGF-I-regulated muscle protein metabolism during aging. J Endocrinol. 1998;156(1):83\u20139.","journal-title":"J Endocrinol"},{"issue":"1","key":"1252_CR223","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-2265.2009.03683.x","volume":"73","author":"WJ Inder","year":"2010","unstructured":"Inder WJ, Jang C, Obeyesekere VR, Alford FP. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1\u2013implications for steroid-induced myopathy. Clin Endocrinol (Oxf). 2010;73(1):126\u201332.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1252_CR224","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1152\/ajpendo.2001.281.6.E1128","volume":"281","author":"K Ma","year":"2001","unstructured":"Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5\u2019-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab. 2001;281(6):E1128\u201336.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1252_CR225","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","volume":"285","author":"K Ma","year":"2003","unstructured":"Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003;285(2):E363\u201371.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"1252_CR226","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1073\/pnas.0604893104","volume":"104","author":"H Amthor","year":"2007","unstructured":"Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA. 2007;104(6):1835\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1252_CR227","doi-asserted-by":"publisher","first-page":"14000","DOI":"10.1038\/s41598-017-13912-0","volume":"7","author":"MM Desgeorges","year":"2017","unstructured":"Desgeorges MM, Devillard X, Toutain J, Castells J, Divoux D, Arnould DF, et al. Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke. Sci Rep. 2017;7(1):14000.","journal-title":"Sci Rep"},{"issue":"11","key":"1252_CR228","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.1210\/jc.2003-030497","volume":"88","author":"W Liu","year":"2003","unstructured":"Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S, Ezzat S. Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab. 2003;88(11):5490\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1252_CR229","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcp.20757","volume":"209","author":"C McFarlane","year":"2006","unstructured":"McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol. 2006;209(2):501\u201314.","journal-title":"J Cell Physiol"},{"issue":"11","key":"1252_CR230","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1073\/pnas.0709144105","volume":"105","author":"AM Haidet","year":"2008","unstructured":"Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA. 2008;105(11):4318\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1252_CR231","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/nu13051508","volume":"13","author":"J Jang","year":"2021","unstructured":"Jang J, Park S, Kim Y, Jung J, Lee J, Chang Y, et al. Myostatin inhibition-induced increase in muscle mass and strength was amplified by resistance exercise training, and dietary essential amino acids improved muscle quality in mice. Nutrients. 2021;13(5):1508.","journal-title":"Nutrients"},{"issue":"5","key":"1252_CR232","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3892\/ol.2023.14049","volume":"26","author":"T Ling","year":"2023","unstructured":"Ling T, Zhang J, Ding F, Ma L. Role of growth differentiation factor 15 in cancer cachexia (review). Oncol Lett. 2023;26(5):462.","journal-title":"Oncol Lett"},{"issue":"5","key":"1252_CR233","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","volume":"178","author":"HH Luan","year":"2019","unstructured":"Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, et al. GDF15 is an inflammation-induced central mediator of tissue tolerance. Cell. 2019;178(5):1231-44e11.","journal-title":"Cell"},{"key":"1252_CR234","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.","journal-title":"Front Immunol"},{"issue":"4","key":"1252_CR235","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"L Lerner","year":"2015","unstructured":"Lerner L, Hayes TG, Tao N, Krieger B, Feng B, Wu Z, et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J Cachexia Sarcopenia Muscle. 2015;6(4):317\u201324.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1252_CR236","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jcsm.12077","volume":"7","author":"L Lerner","year":"2016","unstructured":"Lerner L, Tao J, Liu Q, Nicoletti R, Feng B, Krieger B, et al. MAP3K11\/GDF15 axis is a critical driver of cancer cachexia. J Cachexia Sarcopenia Muscle. 2016;7(4):467\u201382.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"1252_CR237","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cancers13010099","volume":"13","author":"A Molfino","year":"2020","unstructured":"Molfino A, Amabile MI, Imbimbo G, Rizzo V, Pediconi F, Catalano C, et al. Association between growth differentiation factor-15 (GDF-15) serum levels, anorexia and low muscle mass among cancer patients. Cancers (Basel). 2020;13(1):99.","journal-title":"Cancers (Basel)."},{"issue":"11","key":"1252_CR238","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med. 2007;13(11):1333\u201340.","journal-title":"Nat Med"},{"issue":"27","key":"1252_CR239","doi-asserted-by":"publisher","first-page":"e2106868118","DOI":"10.1073\/pnas.2106868118","volume":"118","author":"I Cimino","year":"2021","unstructured":"Cimino I, Kim H, Tung YCL, Pedersen K, Rimmington D, Tadross JA, et al. Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15. Proc Natl Acad Sci USA. 2021;118(27):e2106868118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1252_CR240","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0884533616680354","volume":"32","author":"SJ Peterson","year":"2017","unstructured":"Peterson SJ, Mozer M. Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30\u20139.","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"1252_CR241","first-page":"210","volume":"26","author":"P Klassen","year":"2023","unstructured":"Klassen P, Schiessel DL, Baracos VE. Adverse effects of systemic cancer therapy on skeletal muscle: myotoxicity comes out of the closet. Curr Opin Clin Nutr Metab Care. 2023;26(3):210\u20138.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"1252_CR242","first-page":"523","volume":"27","author":"MC Gonzalez","year":"2024","unstructured":"Gonzalez MC, Cruz-Jentoft AJ, Phillips SM, Prado CM. Muscle loss: does one size fit all? A comment on Bozzetti\u2019s paper. Curr Opin Clin Nutr Metab Care. 2024;27(6):523\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"8","key":"1252_CR243","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jamda.2020.04.002","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Arai H. Asian Working Group for Sarcopenia response to the emphasis on anterior thigh muscle mass in sarcopenia diagnosis. J Am Med Dir Assoc. 2020;21(8):1174\u20135.","journal-title":"J Am Med Dir Assoc"},{"key":"1252_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101883","volume":"86","author":"G Coletta","year":"2023","unstructured":"Coletta G, Phillips SM. An elusive consensus definition of sarcopenia impedes research and clinical treatment: a narrative review. Ageing Res Rev. 2023;86:101883.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1252_CR245","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"1","key":"1252_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-019-00545-w","volume":"105","author":"C Beaudart","year":"2019","unstructured":"Beaudart C, Rolland Y, Cruz-Jentoft AJ, Bauer JM, Sieber C, Cooper C, et al. Assessment of muscle function and physical performance in daily clinical practice\u202f: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. 2019;105(1):1\u201314.","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1252_CR247","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-016-3691-7","volume":"28","author":"JC Menant","year":"2017","unstructured":"Menant JC, Weber F, Lo J, Sturnieks DL, Close JC, Sachdev PS, et al. Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia? Osteoporos Int. 2017;28(1):59\u201370.","journal-title":"Osteoporos Int"},{"issue":"3","key":"1252_CR248","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1249\/MSS.0000000000001448","volume":"50","author":"R Li","year":"2018","unstructured":"Li R, Xia J, Zhang XI, Gathirua-Mwangi WG, Guo J, Li Y, et al. Associations of Muscle mass and strength with all-cause mortality among US older adults. Med Sci Sports Exerc. 2018;50(3):458\u201367.","journal-title":"Med Sci Sports Exerc"},{"issue":"7","key":"1252_CR249","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020;68(7):1410\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1252_CR250","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11357-023-01016-9","volume":"46","author":"WJ Evans","year":"2024","unstructured":"Evans WJ, Guralnik J, Cawthon P, Appleby J, Landi F, Clarke L, et al. Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-How did we get here? Geroscience. 2024;46(1):183\u201390.","journal-title":"Geroscience."},{"issue":"3","key":"1252_CR251","doi-asserted-by":"publisher","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk B, Cawthon PM, Arai H, Avila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024;53(3):afae052.","journal-title":"Age Ageing"},{"issue":"6","key":"1252_CR252","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3945\/ajcn.2009.28047","volume":"90","author":"MJ Delmonico","year":"2009","unstructured":"Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90(6):1579\u201385.","journal-title":"Am J Clin Nutr"},{"key":"1252_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102839","volume":"145","author":"GFP Aleixo","year":"2020","unstructured":"Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;145:102839.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"1252_CR254","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1532-5415.2009.02366.x","volume":"57","author":"PM Cawthon","year":"2009","unstructured":"Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57(8):1411\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1252_CR255","doi-asserted-by":"publisher","first-page":"ziae047","DOI":"10.1093\/jbmrpl\/ziae047","volume":"8","author":"Y Ge","year":"2024","unstructured":"Ge Y, You Q, Gao F, Liu G, Wang L, Li B, et al. Muscle density, but not size, is independently associated with cognitive health in older adults with hip fractures. JBMR Plus. 2024;8(5):ziae047.","journal-title":"JBMR Plus."},{"issue":"12","key":"1252_CR256","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.3390\/curroncol31120578","volume":"31","author":"E Papadopoulos","year":"2024","unstructured":"Papadopoulos E, Wong AKO, Law SHC, Costa S, Cheung AM, Rozenberg D, et al. The role of frailty and myosteatosis in predicting all-cause mortality in older adults with cancer. Curr Oncol. 2024;31(12):7852\u201362.","journal-title":"Curr Oncol"},{"issue":"8","key":"1252_CR257","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/gerona\/glaa305","volume":"76","author":"Y Ezzatvar","year":"2021","unstructured":"Ezzatvar Y, Ramirez-Velez R, Saez de Asteasu ML, Martinez-Velilla N, Zambom-Ferraresi F, Izquierdo M, et al. Physical function and all-cause mortality in older adults diagnosed with cancer: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2021;76(8):1447\u201353.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"1252_CR258","doi-asserted-by":"publisher","first-page":"afac152","DOI":"10.1093\/ageing\/afac152","volume":"51","author":"E Papadopoulos","year":"2022","unstructured":"Papadopoulos E, Helal AA, Jin R, Monginot S, Berger A, Romanovsky L, et al. The impact of pre-treatment muscle strength and physical performance on treatment modification in older adults with cancer following comprehensive geriatric assessment. Age Ageing. 2022;51(7):afac152.","journal-title":"Age Ageing"},{"issue":"1","key":"1252_CR259","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.11.001","volume":"14","author":"TG Dolin","year":"2023","unstructured":"Dolin TG, Mikkelsen MK, Jakobsen HL, Vinther A, Zerahn B, Nielsen DL, et al. The prevalence of sarcopenia and cachexia in older patients with localized colorectal cancer. J Geriatr Oncol. 2023;14(1):101402.","journal-title":"J Geriatr Oncol."},{"issue":"4","key":"1252_CR260","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/jpm11040243","volume":"11","author":"A Bellieni","year":"2021","unstructured":"Bellieni A, Fusco D, Sanchez AM, Franceschini G, Di Capua B, Allocca E, et al. Different impact of definitions of sarcopenia in defining frailty status in a population of older women with early breast cancer. J Pers Med. 2021;11(4):243.","journal-title":"J Pers Med."},{"issue":"11","key":"1252_CR261","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00432-016-2230-4","volume":"142","author":"DD Huang","year":"2016","unstructured":"Huang DD, Chen XX, Chen XY, Wang SL, Shen X, Chen XL, et al. Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study. J Cancer Res Clin Oncol. 2016;142(11):2347\u201356.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1252_CR262","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jss.2016.12.014","volume":"211","author":"CJ Zhou","year":"2017","unstructured":"Zhou CJ, Zhang FM, Zhang FY, Yu Z, Chen XL, Shen X, et al. Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. J Surg Res. 2017;211:137\u201346.","journal-title":"J Surg Res"},{"issue":"6","key":"1252_CR263","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286381","volume":"18","author":"E Papadopoulos","year":"2023","unstructured":"Papadopoulos E, Wong AKO, Law SHC, Zhang LZJ, Breunis H, Emmenegger U, et al. The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancer. PLoS ONE. 2023;18(6):e0286381.","journal-title":"PLoS ONE"},{"issue":"5","key":"1252_CR264","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1252_CR265","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41430-024-01433-9","volume":"78","author":"AF Bullock","year":"2024","unstructured":"Bullock AF, Patterson MJ, Paton LW, Currow DC, Johnson MJ. Malnutrition, sarcopenia and cachexia: exploring prevalence, overlap, and perceptions in older adults with cancer. Eur J Clin Nutr. 2024;78(6):486\u201393.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"1252_CR266","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcsm.13216","volume":"14","author":"T Shukuya","year":"2023","unstructured":"Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, et al. Epidemiology, risk factors and impact of cachexia on patient outcome: results from the Japanese Lung Cancer Registry Study. J Cachexia Sarcopenia Muscle. 2023;14(3):1274\u201385.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"26","key":"1252_CR267","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293\u2013312.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1252_CR268","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ajcn\/76.2.378","volume":"76","author":"J Kim","year":"2002","unstructured":"Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002;76(2):378\u201383.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1252_CR269","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/jcsm.12308","volume":"9","author":"A Scafoglieri","year":"2018","unstructured":"Scafoglieri A, Clarys JP. Dual energy X-ray absorptiometry: gold standard for muscle mass? J Cachexia Sarcopenia Muscle. 2018;9(4):786\u20137.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"1252_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2024.100335","volume":"15","author":"SB Heymsfield","year":"2024","unstructured":"Heymsfield SB, Brown J, Ramirez S, Prado CM, Tinsley GM, Gonzalez MC. Are lean body mass and fat-free mass the same or different body components? A critical perspective. Adv Nutr. 2024;15(12):100335.","journal-title":"Adv Nutr"},{"issue":"778","key":"1252_CR271","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1259\/0007-1285-65-778-895","volume":"65","author":"FF Horber","year":"1992","unstructured":"Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol. 1992;65(778):895\u2013900.","journal-title":"Br J Radiol"},{"issue":"3","key":"1252_CR272","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00421-017-3552-x","volume":"117","author":"CM Toomey","year":"2017","unstructured":"Toomey CM, McCormack WG, Jakeman P. The effect of hydration status on the measurement of lean tissue mass by dual-energy X-ray absorptiometry. Eur J Appl Physiol. 2017;117(3):567\u201374.","journal-title":"Eur J Appl Physiol"},{"key":"1252_CR273","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jot.2018.10.004","volume":"15","author":"K Engelke","year":"2018","unstructured":"Engelke K, Museyko O, Wang L, Laredo JD. Quantitative analysis of skeletal muscle by computed tomography imaging-State of the art. J Orthop Translat. 2018;15:91\u2013103.","journal-title":"J Orthop Translat."},{"issue":"5","key":"1252_CR274","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997\u20131006.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"12","key":"1252_CR275","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539\u201347.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1252_CR276","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1252_CR277","first-page":"ivad020","volume":"36","author":"K Watanabe","year":"2023","unstructured":"Watanabe K, Kinoshita F, Takenaka T, Nagano T, Oku Y, Kosai K, et al. Skeletal muscle area predicts the outcomes of non-small-cell lung cancer after trimodality therapy. Interdiscip Cardiovasc Thorac Surg. 2023;36(2):ivad020.","journal-title":"Interdiscip Cardiovasc Thorac Surg."},{"issue":"8","key":"1252_CR278","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28280","volume":"6","author":"Z Ye","year":"2023","unstructured":"Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, et al. Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer. JAMA Netw Open. 2023;6(8):e2328280.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1252_CR279","doi-asserted-by":"publisher","first-page":"11765","DOI":"10.1038\/s41598-020-68797-3","volume":"10","author":"A Faron","year":"2020","unstructured":"Faron A, Sprinkart AM, Kuetting DLR, Feisst A, Isaak A, Endler C, et al. Body composition analysis using CT and MRI: intra-individual intermodal comparison of muscle mass and myosteatosis. Sci Rep. 2020;10(1):11765.","journal-title":"Sci Rep"},{"issue":"8","key":"1252_CR280","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1177\/0148607114550189","volume":"38","author":"CM Prado","year":"2014","unstructured":"Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr. 2014;38(8):940\u201353.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"2","key":"1252_CR281","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1634\/theoncologist.2019-0600","volume":"25","author":"GFP Aleixo","year":"2020","unstructured":"Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Battaglini CL, Williams GR. Bioelectrical impedance analysis for the assessment of sarcopenia in patients with cancer: a systematic review. Oncologist. 2020;25(2):170\u201382.","journal-title":"Oncologist"},{"key":"1252_CR282","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2891-7-26","volume":"7","author":"M Dehghan","year":"2008","unstructured":"Dehghan M, Merchant AT. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr J. 2008;7:26.","journal-title":"Nutr J"},{"issue":"5","key":"1252_CR283","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jcsm.12210","volume":"8","author":"W Nijholt","year":"2017","unstructured":"Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2017;8(5):702\u201312.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"1252_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109676","volume":"51","author":"W Vongchaiudomchoke","year":"2025","unstructured":"Vongchaiudomchoke W, Cho AR, Mahmoud I, Carli F. Ultrasound for skeletal muscle assessment in surgical oncology: a scoping review. Eur J Surg Oncol. 2025;51(6):109676.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"1252_CR285","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jfmk6040091","volume":"6","author":"JC Carr","year":"2021","unstructured":"Carr JC, Gerstner GR, Voskuil CC, Harden JE, Dunnick D, Badillo KM, et al. The influence of sonographer experience on skeletal muscle image acquisition and analysis. J Funct Morphol Kinesiol. 2021;6(4):91.","journal-title":"J Funct Morphol Kinesiol."},{"issue":"3","key":"1252_CR286","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/jfmk10030299","volume":"10","author":"C Emerson","year":"2025","unstructured":"Emerson C, Kim HK, Irving BA, Papadopoulos E. Reliability and inter-device agreement between a portable handheld ultrasound scanner and a conventional ultrasound system for assessing the thickness of the rectus femoris and vastus intermedius. J Funct Morphol Kinesiol. 2025;10(3):299.","journal-title":"J Funct Morphol Kinesiol."},{"issue":"1","key":"1252_CR287","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00223-023-01124-w","volume":"114","author":"WJ Evans","year":"2024","unstructured":"Evans WJ, Cawthon PM. D(3)creatine dilution as a direct, non-invasive and accurate measurement of muscle mass for aging research. Calcif Tissue Int. 2024;114(1):3\u20138.","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1252_CR288","doi-asserted-by":"publisher","first-page":"glad280","DOI":"10.1093\/gerona\/glad280","volume":"79","author":"AP Pagano","year":"2024","unstructured":"Pagano AP, Montenegro J, Oliveira CLP, Desai N, Gonzalez MC, Cawthon PM, et al. Estimating muscle mass using D3-creatine dilution: a narrative review of clinical implications and comparison with other methods. J Gerontol A Biol Sci Med Sci. 2024;79(4):glad280.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1252_CR289","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1002\/jcsm.13353","volume":"14","author":"E Cheng","year":"2023","unstructured":"Cheng E, Caan BJ, Cawthon PM, Evans WJ, Hellerstein MK, Shankaran M, et al. D3-creatine dilution, computed tomography and dual-energy X-ray absorptiometry for assessing myopenia and physical function in colon cancer: a cross-sectional study. J Cachexia Sarcopenia Muscle. 2023;14(6):2768\u201378.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1252_CR290","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2025.102201","volume":"16","author":"S Cobbing","year":"2025","unstructured":"Cobbing S, Alibhai SMH, Jin R, Monginot S, Papadopoulos E. Impairments in geriatric assessment and their associations with different grip strength cutoffs and components of the Short Physical Performance Battery among older adults with cancer. J Geriatr Oncol. 2025;16(3):102201.","journal-title":"J Geriatr Oncol."},{"issue":"4","key":"1252_CR291","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","volume":"40","author":"HC Roberts","year":"2011","unstructured":"Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011;40(4):423\u20139.","journal-title":"Age Ageing"},{"issue":"4","key":"1252_CR292","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3233\/IES-2010-0389","volume":"18","author":"RW Bohannon","year":"2010","unstructured":"Bohannon RW, Bubela DJ, Magasi SR, Wang YC, Gershon RC. Sit-to-stand test: Performance and determinants across the age-span. Isokinet Exerc Sci. 2010;18(4):235\u201340.","journal-title":"Isokinet Exerc Sci"},{"issue":"10","key":"1252_CR293","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s40520-022-02172-2","volume":"34","author":"JY Ryu","year":"2022","unstructured":"Ryu JY, Kim M, Kim KS, Kim S, Won CW. Chair stand test as a proxy for physical performance and muscle strength in sarcopenia diagnosis: the Korean frailty and aging cohort study. Aging Clin Exp Res. 2022;34(10):2449\u201356.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"1252_CR294","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11556-020-00255-5","volume":"18","author":"XS Yee","year":"2021","unstructured":"Yee XS, Ng YS, Allen JC, Latib A, Tay EL, Abu Bakar HM, et al. Performance on sit-to-stand tests in relation to measures of functional fitness and sarcopenia diagnosis in community-dwelling older adults. Eur Rev Aging Phys Act. 2021;18(1):1.","journal-title":"Eur Rev Aging Phys Act."},{"key":"1252_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112683","volume":"200","author":"C Babiloni-Lopez","year":"2025","unstructured":"Babiloni-Lopez C, Jimenez-Martinez P, Alix-Fages C, Saez-Berlanga A, Juesas A, Gargallo P, et al. Prediction of lower-limb isokinetic strength from functional fitness tests in older adults: a 550-participant cross-sectional study. Exp Gerontol. 2025;200:112683.","journal-title":"Exp Gerontol"},{"issue":"1","key":"1252_CR296","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ptsp.2014.04.004","volume":"16","author":"JB de Araujo Ribeiro Alvares","year":"2015","unstructured":"de Araujo Ribeiro Alvares JB, Rodrigues R, de Azevedo Franke R, da Silva BG, Pinto RS, Vaz MA, et al. Inter-machine reliability of the Biodex and Cybex isokinetic dynamometers for knee flexor\/extensor isometric, concentric and eccentric tests. Phys Ther Sport. 2015;16(1):59\u201365.","journal-title":"Phys Ther Sport"},{"issue":"2","key":"1252_CR297","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-94.","journal-title":"J Gerontol"},{"issue":"3","key":"1252_CR298","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jgo.2021.12.002","volume":"13","author":"FA Almugbel","year":"2022","unstructured":"Almugbel FA, Timilshina N, Papadopoulos E, Al-Showbaki L, Alibhai SMH. The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer. J Geriatr Oncol. 2022;13(3):318\u201324.","journal-title":"J Geriatr Oncol."},{"issue":"2","key":"1252_CR299","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1252_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.101424","volume":"14","author":"E Papadopoulos","year":"2023","unstructured":"Papadopoulos E, Jin R, Monginot S, Alibhai SMH. Performance of the SARC-F in identifying low grip strength and physical performance in older adults with cancer. J Geriatr Oncol. 2023;14(2):101424.","journal-title":"J Geriatr Oncol."},{"issue":"9","key":"1252_CR301","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/cncr.33395","volume":"127","author":"GR Williams","year":"2021","unstructured":"Williams GR, Al-Obaidi M, Dai C, Bhatia S, Giri S. SARC-F for screening of sarcopenia among older adults with cancer. Cancer. 2021;127(9):1469\u201375.","journal-title":"Cancer"},{"issue":"9","key":"1252_CR302","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.jamda.2021.05.011","volume":"22","author":"SN Voelker","year":"2021","unstructured":"Voelker SN, Michalopoulos N, Maier AB, Reijnierse EM. Reliability and concurrent validity of the SARC-F and its modified versions: a systematic review and meta-analysis. J Am Med Dir Assoc. 2021;22(9):1864-76e16.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"1252_CR303","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jgo.2015.07.007","volume":"6","author":"JS Gewandter","year":"2015","unstructured":"Gewandter JS, Dale W, Magnuson A, Pandya C, Heckler CE, Lemelman T, et al. Associations between a patient-reported outcome (PRO) measure of sarcopenia and falls, functional status, and physical performance in older patients with cancer. J Geriatr Oncol. 2015;6(6):433\u201341.","journal-title":"J Geriatr Oncol."},{"issue":"3","key":"1252_CR304","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jamda.2010.09.010","volume":"12","author":"CJ Evans","year":"2011","unstructured":"Evans CJ, Chiou CF, Fitzgerald KA, Evans WJ, Ferrell BR, Dale W, et al. Development of a new patient-reported outcome measure in sarcopenia. J Am Med Dir Assoc. 2011;12(3):226\u201333.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1252_CR305","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0899-9007(98)00171-3","volume":"15","author":"B Vellas","year":"1999","unstructured":"Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15(2):116\u201322.","journal-title":"Nutrition"},{"issue":"9","key":"1252_CR306","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s12603-009-0214-7","volume":"13","author":"MJ Kaiser","year":"2009","unstructured":"Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13(9):782\u20138.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"1252_CR307","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","volume":"2","author":"JM Argiles","year":"2011","unstructured":"Argiles JM, Lopez-Soriano FJ, Toledo M, Betancourt A, Serpe R, Busquets S. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle. 2011;2(2):87\u201393.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1252_CR308","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fphys.2017.00092","volume":"8","author":"JM Argiles","year":"2017","unstructured":"Argiles JM, Betancourt A, Guardia-Olmos J, Pero-Cebollero M, Lopez-Soriano FJ, Madeddu C, et al. Validation of the CAchexia SCOre (CASCO). Staging cancer patients: the use of miniCASCO as a simplified tool. Front Physiol. 2017;8:92.","journal-title":"Front Physiol"},{"issue":"3","key":"1252_CR309","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4143\/crt.2019.695","volume":"52","author":"H Xie","year":"2020","unstructured":"Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S, et al. Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat. 2020;52(3):957\u201372.","journal-title":"Cancer Res Treat"},{"issue":"1","key":"1252_CR310","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10151-024-03040-z","volume":"29","author":"SY Parnasa","year":"2024","unstructured":"Parnasa SY, Lev-Cohain N, Bader R, Shweiki A, Mizrahi I, Abu-Gazala M, et al. Predictors of perioperative morbidity in elderly patients undergoing colorectal cancer resection. Tech Coloproctol. 2024;29(1):4.","journal-title":"Tech Coloproctol"},{"key":"1252_CR311","doi-asserted-by":"publisher","first-page":"1464978","DOI":"10.3389\/fmed.2024.1464978","volume":"11","author":"I Tirnova","year":"2024","unstructured":"Tirnova I, Gasimova M, Akay H, Sariturk C, Guven Mert A, Yenidunya O, et al. Low skeletal muscle mass as a proxy marker of sarcopenia is a risk factor for major complications in older patients undergoing curative colon resections for colon cancer. Front Med (Lausanne). 2024;11:1464978.","journal-title":"Front Med (Lausanne)."},{"issue":"Suppl 5","key":"1252_CR312","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1245\/s10434-016-5606-4","volume":"23","author":"Y Hirasawa","year":"2016","unstructured":"Hirasawa Y, Nakashima J, Yunaiyama D, Sugihara T, Gondo T, Nakagami Y, et al. Sarcopenia as a novel preoperative prognostic predictor for survival in patients with bladder cancer undergoing radical cystectomy. Ann Surg Oncol. 2016;23(Suppl 5):1048\u201354.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"1252_CR313","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/iju.14569","volume":"28","author":"S Yamashita","year":"2021","unstructured":"Yamashita S, Iguchi T, Koike H, Wakamiya T, Kikkawa K, Kohjimoto Y, et al. Impact of preoperative sarcopenia and myosteatosis on prognosis after radical cystectomy in patients with bladder cancer. Int J Urol. 2021;28(7):757\u201362.","journal-title":"Int J Urol"},{"issue":"14","key":"1252_CR314","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.3390\/cancers13143598","volume":"13","author":"GH Kim","year":"2021","unstructured":"Kim GH, Choi KD, Ko Y, Park T, Kim KW, Park SY, et al. Impact of comorbidities, sarcopenia, and nutritional status on the long-term outcomes after endoscopic submucosal dissection for early gastric cancer in elderly patients aged \u2265 80 years. Cancers (Basel). 2021;13(14):3598.","journal-title":"Cancers (Basel)."},{"issue":"48","key":"1252_CR315","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013363","volume":"97","author":"SE Park","year":"2018","unstructured":"Park SE, Hwang IG, Choi CH, Kang H, Kim BG, Park BK, et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore). 2018;97(48):e13363.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"1252_CR316","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s12603-015-0653-2","volume":"20","author":"S Gerard","year":"2016","unstructured":"Gerard S, Brechemier D, Lefort A, Lozano S, Abellan Van Kan G, Filleron T, et al. Body composition and anti-neoplastic treatment in adult and older subjects\u2014a systematic review. J Nutr Health Aging. 2016;20(8):878\u201388.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"1252_CR317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-018-3614-8","volume":"82","author":"JJ Hopkins","year":"2018","unstructured":"Hopkins JJ, Sawyer MB. Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments. Cancer Chemother Pharmacol. 2018;82(1):1\u201329.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"1252_CR318","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","volume":"13","author":"CM Prado","year":"2007","unstructured":"Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264\u20138.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1252_CR319","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/jcsm.12967","volume":"13","author":"C de Jong","year":"2022","unstructured":"de Jong C, Chargi N, Herder GJM, van Haarlem SWA, van der Meer F, van Lindert ASR, et al. The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2022;13(3):1554\u201364.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1252_CR320","first-page":"687","volume":"23","author":"HW Jung","year":"2015","unstructured":"Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW, et al. Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer. 2015;23(3):687\u201394.","journal-title":"Support Care Cancer"},{"issue":"12","key":"1252_CR321","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1016\/j.clon.2021.05.011","volume":"33","author":"I Drami","year":"2021","unstructured":"Drami I, Pring ET, Gould L, Malietzis G, Naghibi M, Athanasiou T, et al. Body composition and dose-limiting toxicity in colorectal cancer chemotherapy treatment; a systematic review of the literature. Could muscle mass be the new body surface area in chemotherapy dosing? Clin Oncol (R Coll Radiol). 2021;33(12):e540\u201352.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1252_CR322","doi-asserted-by":"publisher","first-page":"S431","DOI":"10.1016\/j.annonc.2024.08.576","volume":"35","author":"E Assenat","year":"2024","unstructured":"Assenat E, Ben Abdelghani M, Gourgou S, Perrier H, Akouz FK, Desgrippes R, et al. 507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: final results of the phase II randomized multicenter LEANOX trial. Ann Oncol. 2024;35:S431.","journal-title":"Ann Oncol"},{"issue":"7","key":"1252_CR323","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10147-021-01912-0","volume":"26","author":"T Takeda","year":"2021","unstructured":"Takeda T, Sasaki T, Suzumori C, Mie T, Furukawa T, Yamada Y, et al. The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. Int J Clin Oncol. 2021;26(7):1293\u2013303.","journal-title":"Int J Clin Oncol"},{"issue":"13","key":"1252_CR324","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1245\/s10434-022-12379-2","volume":"29","author":"T Harada","year":"2022","unstructured":"Harada T, Tsuji T, Ueno J, Koishihara Y, Konishi N, Hijikata N, et al. Prognostic impact of the loss of skeletal muscle mass during neoadjuvant chemotherapy on older patients with esophageal cancer. Ann Surg Oncol. 2022;29(13):8131\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1252_CR325","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41430-025-01566-5","volume":"79","author":"M Perrier","year":"2025","unstructured":"Perrier M, Fontaine M, Bertin E, Carlier C, Botsen D, Djelouah M, et al. Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy. Eur J Clin Nutr. 2025;79:576\u201386.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"1252_CR326","first-page":"2075","volume":"24","author":"SI Go","year":"2016","unstructured":"Go SI, Park MJ, Song HN, Kang MH, Park HJ, Jeon KN, et al. Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer. 2016;24(5):2075\u201384.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1252_CR327","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/10428194.2013.816421","volume":"55","author":"H Lanic","year":"2014","unstructured":"Lanic H, Kraut-Tauzia J, Modzelewski R, Clatot F, Mareschal S, Picquenot JM, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma. 2014;55(4):817\u201323.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1252_CR328","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1634\/theoncologist.2017-0193","volume":"23","author":"KS Versteeg","year":"2018","unstructured":"Versteeg KS, Blauwhoff-Buskermolen S, Buffart LM, de van der Schueren MAE, Langius JAE, Verheul HMW, et al. Higher muscle strength is associated with prolonged survival in older patients with advanced cancer. Oncologist. 2018;23(5):580\u20135.","journal-title":"Oncologist"},{"issue":"2","key":"1252_CR329","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.critrevonc.2010.04.003","volume":"78","author":"MT Puts","year":"2011","unstructured":"Puts MT, Monette J, Girre V, Pepe C, Monette M, Assouline S, et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol. 2011;78(2):138\u201349.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"1252_CR330","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3747\/co.22.2623","volume":"22","author":"T Hsu","year":"2015","unstructured":"Hsu T, Chen R, Lin SC, Djalalov S, Horgan A, Le LW, et al. Pilot of three objective markers of physical health and chemotherapy toxicity in older adults. Curr Oncol. 2015;22(6):385\u201391.","journal-title":"Curr Oncol"},{"key":"1252_CR331","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106907","volume":"88","author":"J Wang","year":"2020","unstructured":"Wang J, Cao L, Xu S. Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: a systematic review and meta-analysis. Int Immunopharmacol. 2020;88:106907.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1252_CR332","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/jcsm.12755","volume":"12","author":"Y Takenaka","year":"2021","unstructured":"Takenaka Y, Oya R, Takemoto N, Inohara H. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis. J Cachexia Sarcopenia Muscle. 2021;12(5):1122\u201335.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"1252_CR333","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/CAD.0000000000000982","volume":"31","author":"H Fukushima","year":"2020","unstructured":"Fukushima H, Fukuda S, Moriyama S, Uehara S, Yasuda Y, Tanaka H, et al. Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary report. Anticancer Drugs. 2020;31(8):866\u201371.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"1252_CR334","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.1038\/s41598-024-62825-2","volume":"14","author":"L Ying","year":"2024","unstructured":"Ying L, Xu L, Yang J, Zhang Q. Prognostic significance of CT-determined sarcopenia in older patients with advanced squamous cell lung cancer treated with programmed death-1 inhibitors. Sci Rep. 2024;14(1):12025.","journal-title":"Sci Rep"},{"issue":"6","key":"1252_CR335","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.18632\/aging.205652","volume":"16","author":"Y Yu","year":"2024","unstructured":"Yu Y, Yan L, Huang T, Wu Z, Liu J. Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients. Aging (Albany NY). 2024;16(6):5354\u201369.","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"1252_CR336","doi-asserted-by":"publisher","first-page":"e13685","DOI":"10.1002\/jcsm.13685","volume":"16","author":"SD Tran","year":"2025","unstructured":"Tran SD, Forrest NJ, Guggilla V, Perottino GM, Johnson JL, Sosman J, et al. Weight and blood-based markers of cachexia predict disability, hospitalization and worse survival in cancer immunotherapy patients. J Cachexia Sarcopenia Muscle. 2025;16(1):e13685.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1252_CR337","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.gassur.2024.01.025","volume":"28","author":"X Shao","year":"2024","unstructured":"Shao X, Wu H, Huang C, Yin H, Wang P, Wu X. The correlation of sarcopenia and adverse events of imatinib therapy postoperatively in gastrointestinal stromal tumor through computed tomography quantitative body composition. J Gastrointest Surg. 2024;28(4):375\u201380.","journal-title":"J Gastrointest Surg"},{"issue":"12","key":"1252_CR338","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/1759-7714.13934","volume":"12","author":"X Nie","year":"2021","unstructured":"Nie X, Zhang P, Gao JY, Cheng G, Liu W, Li L. Sarcopenia as a predictor of initial administration dose of afatinib in patients with advanced non-small cell lung cancer. Thorac Cancer. 2021;12(12):1824\u201330.","journal-title":"Thorac Cancer."},{"issue":"19","key":"1252_CR339","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.3390\/cancers14194569","volume":"14","author":"C Dalmiglio","year":"2022","unstructured":"Dalmiglio C, Brilli L, Ciuoli C, Maino F, Valerio L, Sannino I, et al. Effect of pre-existent sarcopenia on oncological outcome of advanced thyroid cancer patients treated with tyrosine kinase inhibitors. Cancers (Basel). 2022;14(19):4569.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"1252_CR340","doi-asserted-by":"publisher","first-page":"982","DOI":"10.17305\/bjbms.2022.7147","volume":"22","author":"A Topcu","year":"2022","unstructured":"Topcu A, Ozturk A, Yurtsever I, Besiroglu M, Yasin AI, Turk HM, et al. The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma. Bosn J Basic Med Sci. 2022;22(6):982\u201391.","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"1252_CR341","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12020-019-02162-x","volume":"68","author":"H Yamazaki","year":"2020","unstructured":"Yamazaki H, Sugino K, Matsuzu K, Masaki C, Akaishi J, Hames K, et al. Sarcopenia is a prognostic factor for TKIs in metastatic thyroid carcinomas. Endocrine. 2020;68(1):132\u20137.","journal-title":"Endocrine"},{"issue":"10","key":"1252_CR342","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2217\/fon-2017-0499","volume":"14","author":"S Rossi","year":"2018","unstructured":"Rossi S, Di Noia V, Tonetti L, Strippoli A, Basso M, Schinzari G, et al. Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations? Future Oncol. 2018;14(10):919\u201326.","journal-title":"Future Oncol"},{"issue":"7","key":"1252_CR343","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/jgh.15336","volume":"36","author":"A Hiraoka","year":"2021","unstructured":"Hiraoka A, Kumada T, Kariyama K, Tada T, Tani J, Fukunishi S, et al. Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: analysis adjusted with inverse probability weighting. J Gastroenterol Hepatol. 2021;36(7):1812\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"1252_CR344","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/nu11081713","volume":"11","author":"CD Liao","year":"2019","unstructured":"Liao CD, Chen HC, Huang SW, Liou TH. The role of muscle mass gain following protein supplementation plus exercise therapy in older adults with sarcopenia and frailty risks: a systematic review and meta-regression analysis of randomized trials. Nutrients. 2019;11(8):1713.","journal-title":"Nutrients"},{"issue":"6","key":"1252_CR345","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3928\/19404921-20230817-03","volume":"16","author":"SH Park","year":"2023","unstructured":"Park SH, Lee H. Effectiveness of combined exercise and nutrition interventions in preventing and improving sarcopenia in frail or healthy older adults: a systematic review. Res Gerontol Nurs. 2023;16(6):312\u201320.","journal-title":"Res Gerontol Nurs"},{"issue":"3","key":"1252_CR346","first-page":"CD0804","volume":"3","author":"AJ Grande","year":"2021","unstructured":"Grande AJ, Silva V, Sawaris Neto L, Teixeira Basmage JP, Peccin MS, Maddocks M. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev. 2021;3(3):CD0804.","journal-title":"Cochrane Database Syst Rev"},{"key":"1252_CR347","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_389942","volume":"43","author":"KC Kadakia","year":"2023","unstructured":"Kadakia KC, Hamilton-Reeves JM, Baracos VE. Current therapeutic targets in cancer cachexia: a pathophysiologic approach. Am Soc Clin Oncol Educ Book. 2023;43:e389942.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"1252_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland Y, Dray C, Vellas B, Barreto PS. Current and investigational medications for the treatment of sarcopenia. Metabolism. 2023;149:155597.","journal-title":"Metabolism"},{"issue":"2","key":"1252_CR349","doi-asserted-by":"publisher","first-page":"afac003","DOI":"10.1093\/ageing\/afac003","volume":"51","author":"C Hurst","year":"2022","unstructured":"Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022;51(2):afac003.","journal-title":"Age Ageing"},{"issue":"1","key":"1252_CR350","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2024.100401","volume":"29","author":"M Izquierdo","year":"2025","unstructured":"Izquierdo M, de Souto BP, Arai H, Bischoff-Ferrari HA, Cadore EL, Cesari M, et al. Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR). J Nutr Health Aging. 2025;29(1):100401.","journal-title":"J Nutr Health Aging"},{"key":"1252_CR351","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104605","volume":"99","author":"HJ Ni","year":"2022","unstructured":"Ni HJ, Hsu TF, Chen LK, Chou HL, Tung HH, Chow LH, et al. Effects of exercise programs in older adults with muscle wasting: a systematic review and meta-analysis: effects of exercise programs in muscle wasting. Arch Gerontol Geriatr. 2022;99:104605.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"1252_CR352","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jcsm.13225","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Shi Q, Nong K, Li S, Yue J, Huang J, et al. Exercise for sarcopenia in older people: a systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1199\u2013211.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"1252_CR353","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","volume":"28","author":"DA Galvao","year":"2010","unstructured":"Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1252_CR354","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1249\/MSS.0000000000003095","volume":"55","author":"LHP Houben","year":"2023","unstructured":"Houben LHP, Overkamp M, van Puk K, Trommelen J, Van Roermund JGH, De Vries P, et al. Resistance exercise training increases muscle mass and strength in prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc. 2023;55(4):614\u201324.","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"1252_CR355","first-page":"971","volume":"20","author":"AS Alberga","year":"2012","unstructured":"Alberga AS, Segal RJ, Reid RD, Scott CG, Sigal RJ, Khandwala F, et al. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer. 2012;20(5):971\u201381.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1252_CR356","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/pcan.2013.22","volume":"16","author":"P Cormie","year":"2013","unstructured":"Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA. Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013;16(4):328\u201335.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1252_CR357","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.smhs.2025.01.002","volume":"7","author":"JL Horawski","year":"2025","unstructured":"Horawski JL, Fleszar-Pavlovic SE, Lopez-Pentecost M, Crane TE, Wheeler MG, Kholodovsky E, et al. The role of resistance training in mitigating cancer-induced cachexia: a systematic review. Sports Med Health Sci. 2025;7:384\u201392.","journal-title":"Sports Med Health Sci."},{"issue":"23","key":"1252_CR358","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.3390\/nu16234036","volume":"16","author":"LBC Pires","year":"2024","unstructured":"Pires LBC, Salaroli LB, Podesta OPG, Haraguchi FK, Lopes-Junior LC. Omega-3 Supplementation and nutritional status in patients with pancreatic neoplasms: a systematic review. Nutrients. 2024;16(23):4036.","journal-title":"Nutrients"},{"issue":"6","key":"1252_CR359","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1016\/j.clnu.2021.04.031","volume":"40","author":"CN Lam","year":"2021","unstructured":"Lam CN, Watt AE, Isenring EA, de van der Schueren MAE, van der Meij BS. The effect of oral omega-3 polyunsaturated fatty acid supplementation on muscle maintenance and quality of life in patients with cancer: a systematic review and meta-analysis. Clin Nutr. 2021;40(6):3815\u201326.","journal-title":"Clin Nutr"},{"issue":"1","key":"1252_CR360","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clnu.2021.11.032","volume":"41","author":"KL Ford","year":"2022","unstructured":"Ford KL, Arends J, Atherton PJ, Engelen M, Goncalves TJM, Laviano A, et al. The importance of protein sources to support muscle anabolism in cancer: an expert group opinion. Clin Nutr. 2022;41(1):192\u2013201.","journal-title":"Clin Nutr"},{"issue":"5","key":"1252_CR361","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","volume":"40","author":"M Muscaritoli","year":"2021","unstructured":"Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr. 2021;40(5):2898\u2013913.","journal-title":"Clin Nutr"},{"issue":"6","key":"1252_CR362","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.ajcnut.2024.08.016","volume":"120","author":"CE Orsso","year":"2024","unstructured":"Orsso CE, Caretero A, Poltronieri TS, Arends J, de van der Schueren MA, Kiss N, et al. Effects of high-protein supplementation during cancer therapy: a systematic review and meta-analysis. Am J Clin Nutr. 2024;120(6):1311\u201324.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1252_CR363","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcsm.12127","volume":"8","author":"Mochamat","year":"2017","unstructured":"Mochamat, Cuhls H, Marinova M, Kaasa S, Stieber C, Conrad R, et al. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project. J Cachexia Sarcopenia Muscle. 2017;8(1):25\u201339.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"1252_CR364","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcsm.12525","volume":"11","author":"CM Prado","year":"2020","unstructured":"Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020;11(2):366\u201380.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"16_suppl","key":"1252_CR365","doi-asserted-by":"publisher","first-page":"e24135","DOI":"10.1200\/JCO.2023.41.16_suppl.e24135","volume":"41","author":"B-H Kim","year":"2023","unstructured":"Kim B-H, Maeng CH, Chon J, Kang WS, Kang K, Woo M, et al. Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial. J Clin Oncol. 2023;41(16_suppl):e24135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1252_CR366","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jcsm.12351","volume":"10","author":"T Naito","year":"2019","unstructured":"Naito T, Mitsunaga S, Miura S, Tatematsu N, Inano T, Mouri T, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73\u201383.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"17_suppl","key":"1252_CR367","doi-asserted-by":"publisher","first-page":"LBA12007","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA12007","volume":"42","author":"TS Solheim","year":"2024","unstructured":"Solheim TS, Laird BJA, Balstad TR, Stene GB, Baracos V, Bye A, et al. Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy. J Clin Oncol. 2024;42(17_suppl):LBA12007.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1252_CR368","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13063-022-06221-z","volume":"23","author":"CH Maeng","year":"2022","unstructured":"Maeng CH, Kim BH, Chon J, Kang WS, Kang K, Woo M, et al. Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial. Trials. 2022;23(1):281.","journal-title":"Trials"},{"issue":"2","key":"1252_CR369","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40266-023-01093-7","volume":"41","author":"G Bahat","year":"2024","unstructured":"Bahat G, Ozkok S. The current landscape of pharmacotherapies for sarcopenia. Drugs Aging. 2024;41(2):83\u2013112.","journal-title":"Drugs Aging"},{"issue":"4","key":"1252_CR370","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12272-024-01493-2","volume":"47","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Feng J, Yu Y, Ling M, Wang X. Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies. Arch Pharm Res. 2024;47(4):301\u201324.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1252_CR371","first-page":"232","volume":"12","author":"S Bhasin","year":"2009","unstructured":"Bhasin S, Jasuja R. Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care. 2009;12(3):232\u201340.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"1252_CR372","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","volume":"2","author":"JT Dalton","year":"2011","unstructured":"Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2(3):153\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1252_CR373","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","volume":"14","author":"AS Dobs","year":"2013","unstructured":"Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013;14(4):335\u201345.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1252_CR374","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11912-016-0522-0","volume":"18","author":"J Crawford","year":"2016","unstructured":"Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, et al. Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials). Curr Oncol Rep. 2016;18(6):37.","journal-title":"Curr Oncol Rep"},{"issue":"15_suppl","key":"1252_CR375","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1200\/jco.2014.32.15_suppl.9618","volume":"32","author":"J Crawford","year":"2014","unstructured":"Crawford J, Johnston MA, Taylor RP, Dalton JT, Steiner MS. Enobosarm and lean body mass in patients with non-small cell lung cancer. J Clin Oncol. 2014;32(15_suppl):9618.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1252_CR376","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jcsm.12083","volume":"6","author":"K Fearon","year":"2015","unstructured":"Fearon K, Argiles JM, Baracos VE, Bernabei R, Coats A, Crawford J, et al. Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle. 2015;6(4):272\u20134.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1252_CR377","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","volume":"5","author":"C Pietra","year":"2014","unstructured":"Pietra C, Takeda Y, Tazawa-Ogata N, Minami M, Yuanfeng X, Duus EM, et al. Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle. 2014;5(4):329\u201337.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1252_CR378","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17(4):519\u201331.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1252_CR379","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","volume":"28","author":"D Currow","year":"2017","unstructured":"Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol. 2017;28(8):1949\u201356.","journal-title":"Ann Oncol"},{"key":"1252_CR380","doi-asserted-by":"publisher","first-page":"S1335","DOI":"10.1016\/j.annonc.2023.10.098","volume":"34","author":"D Currow","year":"2023","unstructured":"Currow D, Chessari S, Bonomi P, Giorgino R, Skipworth R. LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: efficacy and safety in the multinational phase III SCALA program. Ann Oncol. 2023;34:S1335.","journal-title":"Ann Oncol"},{"issue":"6","key":"1252_CR381","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1016\/S1470-2045(16)30057-2","volume":"17","author":"SH Jafri","year":"2016","unstructured":"Jafri SH. Cachexia in patients with cancer. Lancet Oncol. 2016;17(6):e220\u20131.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1252_CR382","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00167-4","volume":"17","author":"GR Williams","year":"2016","unstructured":"Williams GR, Muss HB, Shachar SS. Cachexia in patients with cancer. Lancet Oncol. 2016;17(6):e220.","journal-title":"Lancet Oncol"},{"issue":"24","key":"1252_CR383","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, et al. Ponsegromab for the treatment of cancer cachexia. N Engl J Med. 2024;391(24):2291\u2013303.","journal-title":"N Engl J Med"},{"issue":"18","key":"1252_CR384","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1200\/JCO.23.01965","volume":"43","author":"IM Chen","year":"2025","unstructured":"Chen IM, Johansen JS, Theile S, Silverman LM, Pelz KR, Madsen K, et al. Randomized phase II study of nab-paclitaxel and gemcitabine with or without tocilizumab as first-line treatment in advanced pancreatic cancer: survival and cachexia. J Clin Oncol. 2025;43(18):2107\u201318.","journal-title":"J Clin Oncol"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01252-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01252-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01252-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T15:02:21Z","timestamp":1764255741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01252-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":384,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01252-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.B.H. serves on the medical advisory committee boards of Tanita Corp., Lilly, Abbott, Medifast, and Regeneron and he is on a data safety monitoring committee for Novo Nordisk. G.R.W. declares unrelated compensation as a speaker for Takeda. R.F.D. has received honoraria for advisory boards for Merck & Co. and Incyte and serves on an executive steering committee for Pfizer, Inc. Authors E.P., B.A.I., J.C.B., S.S., and S.M.H.A. declare they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}